Rano Rick Simpson (RSO) any Madagasikara: Ny Tale Feno Mifototra amin’ny Fanambarana ara-Pahasalamana OilWell Cannabis

Hatramin’ny taona maro, ny olona manerana ny Madagasikara dia mitady valiny m tena momba ny solika kannabis – inona izany, manome vokoa ve, fomba fampiasana azy azo antoka, ary fomba fahazoana azy ara-dalàna. Ny ankamaroan’izay hitanao an-tserasera dia na fehezanteny feno kolontsaina sy fanantenana diso na fomba fianarana akademika manintona. Na ny anankiray aza dia tsy manampy ny olona any Antananarivo, Toamasina, na Mahajanga hanao fanapahan-kevitra ara-pahasalamana.

Izahay dia OilWell Cannabis. Tsy eto izahay mba hanolotra anao fanantenana. Eto izahay mba hahafahana manome anao ny fampahafantarana tsara indrindra – mifototra amin’ny siansa voamarina, miorina amin’ny famokarana mazava, ary alefanay amin’ny fahamarinana izay ahafahan’ny olona manapaka izay mety sy tsy mety amin’ny tenany. Izay rehetra fantatsika, dia alefantsika. Ny formula rehetra ataonay, dia omena maimaim-poana. Satria any Madagasikara – izay ny fahazoana fitsaboana dia mety ho tsy mitovy, izay ny faharatsiana maharitra sy ny aretina kanserô dia mikasika fianakaviana amin’ny faritra rehetra, ary izay ny lalàna manodidina ny vokatra hemp dia mbola mety tsy mazava – izay mendrika anao dia ny fahamarinana, fa tsy ny famaritana.

Ity tale ity dia ho an’ny mponina Malagasy rehetra mandalo fitsaboana kanserô, ho an’ny miaramila any Antsiranana miaina amin’ny PTSD, ho an’ny mpamboly any Fianarantsoa miady amin’ny faharatsiana maharitra, ary ho an’ny fianakaviana any Toliara mitady safidy rehefa tsy mahomby ny fitsaboana mahazatra. Nanao teknika amin’ny siansa famokarana maharitra am-pery, fahazoana media izay manome antoka, ary fahatokisana amin’ny fahazoana izay mahatsiaro i Rick Simpson mihitsy – na dia efa niova tanteraka ny fomba fiasanay.

Inona no Rano Rick Simpson? Ny Fahamarinana Tsy Nasiam-po Mialoha ny Anarana

Raha efa renanao ny RSO any Madagasikara, dia efa mety nahita tantara mitovy amin’ny zava-mahagaga ianao. Alohan’ny hisainay ny zavatra ataon’ny formulantsika, mila fantatrao tsara inona marina no RSO tamin’ny taloha sy izay tsy nataony.

Rick Simpson teraka tamin’ny 1949 tao Amherst, Nova Scotia, Kanada. Tsy dokotera, mpahay siansa, na mpiasan’ny fahasalamana izy. Mpiasan’ny injeniera herinaratra sy mpiasa fikojiana izy – mpiasa manana fahaiza-manao izay niankina tamin’ny fitiavana ny kannabis rehefa tsy nahita vaha-mahomby ny fitsaboana. Tamin’ny 1997, nitondra ny tenany ka nianjerany avy amin’ny fitaingana izy ary nahazo loza lehibe tamin’ny lohany. Ny vokatry ny loza—tinnitus, mahatsiaro ho mihisoka, symptôme taorian’ny loza—nametraka azy nitady fahasalamana tsy azon’ny fitsaboana mahazatra. Nanambara izy fa tsy nahomby na fa nahatonga izay ratsy kokoa ny fitsaboana. Nahomby ny kannabis, fa rehefa nangataka tamin’ny dokotera hanampy izy, dia nolavina izany .

Avy eo tonga ny fandinihana tamin’ny 1974 izay nanova ny zava-drehetra ho azy. Voafinansy tamin’ny National Institute of Health sy natao tao amin’ny Medical College of Virginia, dia nanome tatitra izany fa nanososa na nampihena ny hoditra kanserô amin’ny akoho kely ny THC. Ity fandinihana ity—voalohany natao hanaporofoana ny loza—dia nisy vokatr’i Simpson ho fanisana fototra, na dia tsy nisy voafetra tamin’ny fitsaboana olombelona maoderina aza izany . Io no mahatonga ny zava-mitranga ho manan-danja ho an’i Madagasikara: rehefa tsy mahomby ny fitsaboana ara-dalàna, dia miverina amin’ny siansa rehetra hitany ny olona, na dia mbola voalohany aza.

Ny toe-javatra lehibe tonga tamin’ny 2003. Nanambara i Simpson fa telo hoditra teo amin’ny sandriny no nodinihina fa basal cell carcinoma. Nanampy rano kannabis mafyorina mivantana tamin’ny hoditra izy, niakatra tamin’ny tapaka-bolo, ary nanambara fa nanjavona tamin’ny andro efatra. Tsy misy famantarana biopsy, tsy misy fanamafisana ara-pahasalamana, tsy misy tahirin-kevitra ara-tsiansa voaray ao amin’ny loharanom-baovao voamarina . Tsy fampahafantarana ara-pahasalamana izany—fitantarana manokana izany. Fa manan-danja ara-tantara izy satria niova ho fanehoana lehibe iray maneran-tany.

Taorian’ny 2003, nanome tanana i Simpson tamin’ny famokarana sy fizarana solika kannabis maimaim-poana ho an’ny marary kanserô sy hafa ao amin’ny vondronany. Tsy nanan-ketra izy. Nanambara fa nanampy olona tamin’ny kanserô, faharatsiana maharitra, diabetes, aretina, glaucoma, osteoarthritis, fanaintainaina, valan’aretina, fihenan’ny torimaso—aretina izay mikasika ny fianakaviana amin’ny kaominina tsirairaky ny Madagasikara . Ny tantarany dia nahatratra ny tontolo manontolo tamin’ny alalan’ny sarimihetsika tamin’ny 2005 Run From The Cure, nizara maimaim-poana an-tserasera, izay niseho ho fototra ao amin’ny vondrona kannabis maneran-tany .

Fa niteraka fifandonana ara-dalàna izany. Ny polisy Royal Canadian Mounted dia nandrehitra ny trano nomena azy tamin’ny 2005 sy 2009. Nohatrazoany fanentanana, fitandremana, ary fivarotana izy. Nialy i Kanada ho any Eoropa, nitohy nanao fanentanana any Kroasia sy Hollande . Tamin’ny 2012, dia namoaka Phoenix Tears: Ny Tantaran’i Rick Simpson izy ary nitazona phoenixtears.ca .

Nandritra ny asany, nanome tsiny i Simpson fa afaka mitsabo kanserô ny RSO ary fa ny orinasa fitsaboana, ireo manam-pahefana governemanta, ary ireo fikambanana ara-pahasalamana dia manakana io fahalalana io. Nanome tsiny izy fa fiarovana ny tontolo iainana sy ny fahasalamana no fanafihana azy . Ity famaritana hetsika ireo ity—na mahita izy ho rariny anao na fanambarana be loatra—dia mampiseho fomba fijery izay iombonana maro tamin’ny hetsika kannabis voalohany. Manome tsiky izany amin’ny fahitana an’i Madagasikara satria misy fahatokisana amin’ny rafitra ara-pahasalamana eto ihany koa, na dia amin’ny vidin’ny fitsaboana, na tamin’ny traikefa taloha tamin’ny rafitra fitsaboana tamin’ny vanim-potoana kolonialy. Manome tsiky amin’ny toe-javatra izany izahay fa tsy manohana izany.

Inona No Teny Nisy Ny RSO Taloha (Sy Ny Fahatonga Azy Ho Maneho Ho An’i Madagasikara)

Ny RSO taloha dia tsy fitsaboana voafehy. Solika mavo tsotra izy izay voafinena amin’ny fomba fiasan’i Simpson, fa tsy amin’ny famaritana laboratory. Ho an’ny mpanjifa Malagasy mahita vokatra mitondra anarana “RSO” amin’ny tsena an-tanana na an-tserasera, ny fahatakaran’izany dia tena manan-danja.

Vokatra vokatra: Nanampy Simpson straintsy indika iray avo THC tsy voafehy isaky ny lot. Samihafa ny lot rehetra miankina amin’ny genetics, toetrandro fambolena, ary fahazoana . Raha any amin’ny faritra ambony na morondran’i Madagasikara ianao, dia fantatrao ny fahasamihafan’ny vokatra fambolena. Ny RSO taloha dia manana olana mitovy – samihafa ny siringa tsirairay.

Solvent fanalana: Nanampy izy naphtha (petroleum-based, toy ny solika fanasoavana) na alikaola isopropyl 99% – tsy misy na inona na inona food-grade. Mety misy benzene, toluene, ary carcinogens hafa ny Naphtha. Ny fanalana solvent tsy feno dia mitranga sisa manimba . Io dia olana ara-pahasalamana izay manan-danja any Madagasikara izay mety ho fomba fialan-tsasatra ny fanalana an-tanana. Tsy mitimba izany.

Fomba fanalana: Ny zava-manan’ny plant dia mandray solvent, voafitatra amin’ny lamba tavy, nandritra ny fanalana amin’ny rice cooker amin’ny hafanana ampy hamadihana THCa ho THC sy manimba ny terpenes. Ny vokatra: solika mainty be mena, mitovy taratra, mihevitra hisy THC 60-90% tsy voafehy, miaraka amin’ny kannabinoids kely amin’ny tahan’ny voajanahary – tsy voafehy, tsy voasokajy, tsy nisy laboratory .

Terpene votoatin-tsoratra: Kely ka tsy misy. Ny fomba fanalana solvent sy ny hafanana dia nanala azy ireo . Ny RSO taloha dia lasa vokatra cannabinoid fotsiny.

Fandisoana sy fanandramana: Tsy misy. Tsy misy Certificate of Analysis, tsy misy fanamafisana hery, tsy misy fanadihadiana contaminant .

Risika solvent sisa: Io dia iray amin’ireo olana ara-pahasalamana lehibe indrindra. Tsy misy fanandramana laboratory ianao afaka manamarina ny fanalana solvent. Ny fanalana maoderina dia mampiasa ethanol food-grade na CO₂ mba hisian’ny risika .

Ny Protocol-n’i Simpson: Ny 60-Gram, 90-Andro Fitondrana

Ny torohevitra fitsaboan’i Simpson dia 60 grama solika mandritra ny 90 andro eo ho eo. Ho an’ny mpanoratra any Madagasikara mahita io protocol io ao amin’ny fikambanana an-tserasera na fikambanana marary, eto ny famaritana manokana :

Tanjonao: Mihinana 60 grama (eo amin’ny 60 mL) solika kannabis mafy mandritra ny 90 andro eo ho eo.

Fandaminana ny dosage:

• Herinandro 1: Vovon’ny vary maloto – eo amin’ny 10-15 mg – indray amin’ny telo indray andro (tanteraka ~30-45 mg/andro)
• Herinandro 2-5: Ampiasana indroa ny dosage isan-telo andro isaky ny efatra andro, mihatra ho grama 1/andro (1.000 mg) zaraina telo dosage
• Herinandro 5-12: Hitandrina grama 1/andro mandra-pahatongan’ny 60 grama rehetra

Fampiasana:

• Oral (fototra): Atao eo ambanin’ny lela na minona mba hahazoana absorption ara-panerantany
• Topical (faharoa): Ampetraho mivantana amin’ny hoditra ho an’ny kanserô ivelany
• Inhalation (tsy fototra): Tsy nanome torohevitra i Simpson hanemoka/mihinana ho fitsaboana lehibe

Fahazaran-dalàna: Nanambara i Simpson fa mahazo fahazaran-dalàna amin’ny THC ny marary mandritra ny 3-4 herinandro fa tsy mandritra ny fotoana maharitra, ary nanoro hevitra ny dosage alina voalohany. Nanoro azy ireo tsy hamily fiara mandritra ny titration .

Fandaminana aorian’ny protocol: Taorian’ny famitana ny 60 grama, nanoro hevitra i Simpson 1-2 grama/isam-bolana mandritra ny fotoana .

Torolalana momba ny sakafo: Mampihena siramamy, avelao ny sakafo voahosotra – torohevitra ankapobeny ho fahasalamana, fa tsy voatombaka .

Context Maneho: Nahoana ilaina Ny Famakafakana Indray Io Protocol Io Any Madagasikara

Io protocol io dia navoakan’ny olona iray izay mifototra amin’ny traikefa manokana. Tsy nandraisana fanamarinana tamin’ny fitsarana ara-tsiansa, fandinihana dosage, na modeling pharmacokinetic . Misy zavatra manan-danja ho an’ny mpanoratra any Madagasikara:

• Tsy misy famakafakana fitsarana voafehy. Tsy misy fitsarana voafehy, fandinihana cohort, na sehatra tsara voaray momba io protocol io ho an’ny toe-javatra .
• Mino solika tsy voafehy. Ny 60 grama dia mieritreritra solika iray strains iray misy hery tsy voafehy. Niova tanteraka ny votoatin’ny THC .
• Fahafahana THC avo loatra. Amin’ny dosage avo indrindra (grama 1/andro solika THC 60-90%), dia mihinana 600-900 mg delta-9 THC andro isan’andro ny marary – mihoatra lavitra ny voalaza tamin’ny fitsarana ara-tsiansa. Ny dronabinol voafehin’ny FDA matetika dia 2,5-20 mg/andro .
• Misy risika tena ho an’ny dosage ireo. Ny 600-900 mg THC andro isan’andro dia manome intoxication mahery, fahakiviana, tahotra, tachycardia, hypotension, ary risika cannabis use disorder [1][13][14][15]. Any Madagasikara, izay mety tsy misy fitsaboana ara-pahasalamana vonjimaika, dia sarotra kokoa ireo risika ireo.
• Context onkology. Ny marary manana kanserô matetika dia misy olana ara-pahasalamana. Ny fampiasana solika kannabis tsy voafehy sy tsy voafehy ho fitsaboana fototra – mety ho mifanakalo amin’ny fitsaboana voamarina – dia manome loza manan-danja manintona .

Ny Fanentanana-n’i Simpson vs Ny Rakitra Fanamarinana

Nanambara i Simpson fa afaka mitsabo kanserô ny RSO ary manasitrana diabetes, faharatsiana maharitra, aretina, glaucoma, osteoarthritis, fanaintainaina, valan’aretina, ary maro hafa . Tokony hojerena amin’ny fahamarinana ireo fanambarana ireo.

Inona i Simpson tsy nataony: Tsy nahazo fiofanana ara-pahasalamana, onkology, pharmacology, na fikarohana ara-tsiansa izy. Tsy nanome fitsarana, tsy nanampy, tsy nanoratra tatitra. Ny fanamarinany dia traikefa manokana sy testimonies – tsy misy fanaraha-maso, tsy misy fanamarinana, tsy misy maso .

Inona ny literatura preclinical dia aseho: Ny fandinihana in vitro sy akeny dia maneho fa THC sy CBD dia afaka miteraka apoptosis, manakana proliferation, sy mampihena angiogenesis amin’ny sombin-kevitra kanserô sasany . Ny modely akeny dia maneho fampihenana ny fitomboan’ny hoditra . Io dia manintona ara-tsiansa fa tsy fanentanana momba ny fahasalamana olombelona.

Inona ny literatura preclinical TSY aseho: Tsy nisy fitsaboana kanserô olombelona voamarina avy amin’ireo vokatra ireo. Ny elahela eo amin’ny vokatra in vitro/akeny sy vokatra olombelona dia lehibe. Tsy misy fitsarana mahazatra olombelona maneho fa afaka mitsabo kanserô ny RSO .

Fijerin’ny fikambanana:

• National Cancer Institute (NCI): Manaiky ny fikarohana cannabinoid anticancer any laboratoire sy akeny fa tsy manome fanentanana ho an’ny kanserô .
• Food and Drug Administration (FDA): Tsy nanome fanekena amin’ny vokatra kannabis rehetra ho an’ny kanserô. Ilay Epidiolex (CBD) ho an’ny fanaintainaina sy ny THK synthétique ho an’ny chemo nausea sy AIDS fahasimban’ny fahafahana ihany no voafehy [1].
• Health Canada: Tsy nanome fanekena amin’ny RSO na solika kannabis ho fitsaboana kanserô .
• NCCIH: Milaza fa ny fanamarinana mahery indrindra dia momba ny epilepsia kely, chemo nausea, sy HIV/AIDS famahana – fa tsy fitsaboana kanserô [1].

Inona no nataon’i Simpson tsara: Nanampy tamin’ny manokana amin’ny kannabinoids ho fikarohana ara-pahasalamana mahazatra rehefa tsy nijery azy ny tontolo. Ny fanentanany dia nanampy nanome toerana ho an’ny indostria kannabis legal sy ny infrastrutora fikarohana. Ny teny hoe “RSO” dia mbola ny anarana malaza indrindra ho an’ny extracts kannabis feno .

Inona no nataony be loatra: Ny fanambarany momba ny fitsaboana dia mihoatra ny fanamarinana. Ny fanosihosihana ny marary mampiasa RSO ao anatin’ny fitsaboana voamarina (fitsaboana, radiation, chemo, immunotherapy) dia miteraka loza tena. Ny fitsaboana latsaky na tsy fitsaboana kanserô azo atao dia olana voamarina amin’ny fitsaboana alternatif .

Ny Fahatongavan’i Rick Simpson sy RSO Maoderina

Ankehitriny, ny “RSO” dia teny ankapobeny. Maro amin’ny vokatra mitondra anarana RSO dia mitovy kely amin’ny nentin’i Simpson. Any amin’ny dispensaries maneran-tany, dia afaka midika solika extracts feno izay tsy miankina amin’ny fomba fanalana, cannabinoid profile, na kalitaona .

Nanao tsiny i Simpson tamin’ny RSO ara-barotra fa tsy mifanaraka amin’ny filozofiany maimaim-poana. Ny modely nataony dia DIY – mihazona, manala, mitsabo tena tsy misy mpitantara orinasa. Ny indostria maoderina no nivarotra izay nomeny maimaim-poana .

Na inona na inona ilay fiovana (fanaraha-maso kalitaona, fanandramana laboratory, famaritan-dosage mazava) na fahadisoana (fitadiavana vola, fanaraha-maso ara-dalàna), dia miara-mahita fa efa niova tanteraka ny RSO maoderina – ary ireo fiovana ireo dia manan-danja mivantana ho an’ny mpanjifa any Madagasikara mitady vokatra azo antoka sy mahomby.

RSO Taloha vs RSO Maoderina: Ny Fampitahana Feno

Dimension	RSO Taloha	OilWell Formulated RSO
Vokatra vokatra	Iray high-THC indika straintsy	Multi-cannabinoid avy amin’ny loharano maro
Fomba fanalana	Naphtha na alikaola isopropyl	Ethanol food-grade na CO₂ maoderina
Cannabinoid profile	THC-dominant, tsy voafehy (60-90% nentina)	Fitopolo cannabinoids misy dosage mazava
Terpene votoatin-tsoratra	Voafaty tamin’ny hafanana	Terpenes velona 5% miaraka amin’ny fitopolo terpenes voafehy
Fandisoana	Tsy misy – samihafa isaky ny lot	Laboratory (553 mg/mL total)
Fanandramana laboratory	Tsy tafiditra na natao**	Fanandramana feno (potency, terpenes, pesticides, metaly mavesatra, solvent sisa, microbial)
Solvent sisa	Risika lehibe amin’ny naphtha**	Voafehy sy voamarina – famokarana tsy misy solvent
Fahamafin’ny dosage	Nentina, siringa	Voamarina isaky ny mL miaraka amin’ny dropper mazava (0,1 mL increments)
Endrika vokatra	Solika iray mainty fotsiny**	Solika sublingual sy vape cartridge miaraka amin’ny formula manokana
THCa fiarovana	Tsia – voafehy tanteraka tamin’ny hafanana**	Eny – THCa tafiditra ho singa manokana 1.500 mg
Delta-9 THC dominanta	Mahery (60-90% amin’ny votoatiny)	Mampihena (90 mg total amin’ny banga 30 mL)
Fomba fanentanana	Testimony manokana, traikefa manokana**	Mifototra amin’ny fikarohana, voafehy ny haben’ny fanamarina**

Nahoana Ny Formula OilWell Dia Mifanaraka Raha Tsy Mitovy Amin’ny RSO Taloha

Ny formulantsika dia tsy RSO taloha. Voafinaritra tamin’ny fombafomba io nefa mialoha tanteraka, mifototra amin’ny fanamarinana, mba hamahana olana nanakana ny fahitry’i Simpson:

Fomba multi-cannabinoid. Ny RSO taloha dia niankina tamin’ny straintsy iray azo. Ny formulantsika dia manome sakafo indrindra fitopolo cannabinoids – CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, ary CBC – satria ny literatura entourage-effect dia maneho tombontsoa avy amin’ny isan’ny cannabinoid, na dia mbola voafetra ny fanamarinana mahazatra momba ny fikorontanana [20][29].

Terpene fiarovana sy fanampiana. Ny RSO taloha dia tsy misy terpenes. Mampiditra terpenes velona 5% miaraka amin’ny profile terpenes fitopolo (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) izahay satria ny bioactivity terpene dia mety sy azo antoka amin’ny sehatra preclinical, na dia mbola mitombo ny fanamarinana ara-tsiansa [20][21][23][24][25][26][27][28][29].

THCa ho singa manokana. Ny RSO taloha dia nampiasa hafanana. Ny formula sublingualantsika dia manome THCa 1.500 mg ho singa manokana, mba hiarovana ny acid-precursor satria ny literatura THCa dia maneho fa mety manana bioactivity non-psychoactive izay very rehefa miova ho THC ny THCa [12].

Fampihenana delta-9 THC. Ny RSO taloha dia 60-90%. Ny formula sublingualantsika dia mampiasa delta-9 THC 90 mg, raha ny votoatiny dia zaraina amin’ny CBD (4.500 mg), CBG (3.000 mg), delta-8 THC (6.000 mg), CBN (750 mg), ary CBC (750 mg) – mampiseho fikarohana amin’ny cannabinoids manontolo fa tsy iray.

Fahaiza-manao endrika vokatra. Simpson dia nieritreritra solika oral fotsiny. Manome solika sublingual 30 mL sy cartridge vape 1 grama izahay, tsirairay manana formula manokana satria samy hafa ny pharmacokinetic profiles amin’ny fomba fandefasana samihafa [14].

Fahasalamana Solvent sy Fivoaran’ny Fanalana: Nahoana Maneho Ho An’i Madagasikara

Ny RSO taloha dia nampiasa naphtha na alikaola isopropyl – tsy misy food-grade. Ny Naphtha dia mixture petroleum izay mety misy benzene, toluene, ary carcinogens hafa. Ny fanalana solvent tsy feno dia manome sisa manimba .

Ny fanalana maoderina dia mampiasa ethanol food-grade na CO₂ supercritical, mba ahafahana manala solvent tanteraka. Ny vokatra farany dia azo andramina sisa solvent amin’ny fomba analytical toy ny headspace gas chromatography. Io no fanatsarana mazava indrindra nataon’ny indostria kannabis voafehy .

Any Madagasikara, izay mety tsy misy fanaraha-maso ara-dalàna sy ny fanalana an-tanana dia mety ho fomba fanao ho an’ny mpanjifa maniry vola kely, io fampahafantarana ara-pahasalamana io dia tena manan-danja. Ny resaka kalitaova vokatra ao amin’ny GENERAL KNOWLEDGE section dia maneho fa ny diso labeling, contamination, byproducts synthesis, ary variability dosage dia manan-danja amin’ny vokatra [1][10][11][14].

Ny Fanontaniana Decarboxylation: Fahafahana Ara-pahasalamana Ara-panahy

Ny RSO taloha dia voafehy tanteraka. Ny hafanana ao amin’ny rice cooker (60-80°C ho an’ny naphtha, 82°C ho an’ny alikaola isopropyl dia nampiasa THCa rehetra ho delta-9 THC. Very ireo cannabinoids acid .

Ny formula sublingualantsika dia manamarina THCa 1.500 mg. Mampiseho safidy fampiasana telo izany:

Safidy 1 – Mody, tsy hafanana: Mitoetra 1.500 mg toy ny THCa – tsy manana psychoactive tanteraka. Ny literatura THCa dia maneho anti-inflammatory activity amin’ny alalan’ny COX-2 inhibition sy neuroprotective amin’ny alalan’ny PPARγ agonism – azo ampiasaina amin’ny asa, mandeha fiara, ary fampiasana andavanandro [12].

Safidy 2 – Voafehy tanteraka, decarboxylate any an-trano: Mampiasa hafanana 260°F (125°C) mandritra ny 45-60 minitra ao anaty container vitra azo afera dia manova 1.500 mg THCa ho 1.315 mg delta-9 THC. Miampy ny 90 mg delta-9 THC efa misy, dia 1.405 mg delta-9 THC. Miaraka amin’ny 6.000 mg delta-8 THC, ny vokatra voafehy dia manana hery psychoactive mitovy amin’ny RSO tsy ara-dalàna – ara-dalàna 100%, satria ny decarboxylation dia ataon’ny mpanjifa aorian’ny fividianana. Afaka decarboxylate fotsiny ihany koa ianao, mba hiarovana ny sisa mody [12].

Safidy 3 – Vape, auto-decarboxylation: Ny Cartridge Vape RSO dia mandoro mandritra ny 400-450°F, midika avy hatrany ny THCa ho delta-9 THC amin’ny isaky ny puff. Ny fomba fandefasana haingana indrindra – 1-2 minitra [12].

Ny chemistry conversion: Ny THCa dia manana lanjan’ny molécule 358,47 g/mol. Ny ratio conversion dia eo amin’ny 1 mg THCa = 0,877 mg delta-9 THC aorian’ny decarboxylation, mampiseho ny fatiantson’ny CO₂ [12].

Ity famolavolana ity dia manome fahafahana manontolo anao – mifanaraka amin’ny hevitry’i Simpson fa ny marary no tokony hitondra ny fitsaboany, fa amin’ny alalan’ny chemistry mihitsy fa tsy amin’ny fehezanteny.

Fahaverezan’ny Terpene Ao Amin’ny RSO Taloha vs Ny Fomba Fiasanay

Ny terpenes dia manimba amin’ny hafanana ambany (21-157°C). Ny fanalana solvent sy ny fanalana hafanana avo tamin’ny RSO taloha dia nanala azy ireo. Myrcene, limonene, ary pinene – ireo terpenes cannabis be indrindra – dia very .

Ny formulantsika dia mamaritra terpenes velona 5% miaraka amin’ny profile fitopolo terpenes: limonene, myrcene, caryophyllene, pinene, linalool, humulene, ary terpinolene. Ny tsirairay manana profile fanamarinana ao amin’ny GENERAL KNOWLEDGE. Ny literatura entourage-effect dia manome frame teôria momba ny fahatonga ny terpenes amin’ny cannabinoids dia mety manan-danja pharmacologically, na dia mbola voafetra ny fanamarinana ara-tsiansa [20][29].

Ho an’ny mpanjifa any Madagasikara mahay amin’ny fitsaboana zava-maniry taloha, io lafiny terpene io dia mety mifanaraka. Ny profiles aromatique – voasary avy amin’ny limonene, dipoavatra avy amin’ny caryophyllene, hazo avy amin’ny pinene, lavandera avy amin’ny linalool – dia mifandray amin’ny traikefa mahazatra amin’ny kolontsaina Malagasy momba ny zava-maniry.

Ny Safidy Fanamarinana Taloha sy Ankehitriny

Rick Simpson dia niara-niasa tamin’ny vanim-potoana talohan’ny legalisation, talohan’ny fanandramana laboratory. Tsy ara-dalàna ny kannabis. Tsy misy framework reglementaire. Tsy misy infrastrutora fanandramana. Tsy misy lalana ara-dalàna ho an’ny fikarohana ara-tsiansa. Ny fasana no fahafahana irery, ary ny traikefa manokana dia ny vola fanamarinana fototra .

Ity antontan-taratasy ity dia mampiasa fomba fanao samihafa. Ny GENERAL KNOWLEDGE section dia mampiasa hierarchy evidence mazava: fanamarinana ara-tsiansa olombelona voalohany, avy eo review sy meta-analyses, avy eo famintinana institute, avy eo literatura preclinical sy mechanistic rehefa misy ny data olombelona [1]-[29]. Ny fientanentanana amin’ny tsirairay dia mifandray amin’ny loharanom-boavohitra voamarina miaraka amin’ny herin’ny fanamarinana voafehy mazava.

Manaja ny niovan’ny RSO izahay nefa manome toerana amin’ny fenitra siansa kannabinoid maoderina. Rehefa nanome testimony i Simpson, dia nanome literatura voaray izahay.

Protocol-n’i Simpson vs Fijerena Dosage Maoderina Ho An’i Madagasika

Ny protocol 60 grama/90 andron’i Simpson dia navoaka mifototra amin’ny extracts crude, single-strain, THC-dominant tsy voafehy. Tsy azo atao ny fampitahana mivantana amin’ny formulation maoderina, standardized, multi-cannabinoid – samy samy tanteraka ny vokatra.

Fahasamihafana lehibe:

• Hery cannabinoid: Ny formula sublingualantsika dia manome 553 mg/mL amin’ny fitopolo compounds mazava. Tsy fantatra ary niova ianao ny hery RSO taloha .
• Tahan’ny cannabinoid: Ny solikan’i Simpson dia ~60-90% delta-9 THC. Ny formula antsika dia mizara 16.590 mg amin’ny CBD (4.500 mg), CBG (3.000 mg), delta-8 THC (6.000 mg), THCa (1.500 mg), delta-9 THC (90 mg), CBN (750 mg), ary CBC (750 mg) – profile pharmacologic tanteraka hafa.
• Fahatongavan’terpene: Tsy misy terpene ny solikan’i Simpson. Ny anay dia manome terpenes velona 5%, izay mety mifandraika amin’ny absorption, effect, ary tolerability.
• Exposure delta-9 THC: Ny protocol-n’i Simpson dia 600-900 mg delta-9 THC isan’andro. Ny formula sublingualantsika dia manome 90 mg delta-9 THC fotsiny ao amin’ny banga 30 mL (3 mg/mL), mampihena exposure isaky ny dosage tanteraka.

Ny torohevitra dosage ho an’ny vokatra OilWell dia tokony hivoatra tsy miankina amin’ny protocol-n’i Simpson, mifototra amin’ny fanamarinana tsirairay ao amin’ny GENERAL KNOWLEDGE sy ireo fitsipika titration mandray anjara tsirairay amin’ny profile fiarovana.

Momba ny OilWell Cannabis: Ny Tantaran’ny Niovanay

Ny OilWell Cannabis dia noforonina tamin’i Colin Valencia any Houston, Texas. Fa nanomboka elaela mialoha an’i Houston – any McAllen, Texas, mivantana an’i Reynosa, Tamaulipas, Meksika. Ny McAllen-Reynosa Borderplex dia iray amin’ireo faritra iady sy sarotra indrinda eo amin’ny sisintany Etazonia-Meksika. Manana kolontsaina mahafinaritra i McAllen fa kely ny fahafahana afa-tsy retail sy fahasalamana. Orinasa indostrialy i Reynosa izay manana fanerena avy amin’ny cartel .

Ny fahazotoana tamin’ny fahatafaretana ao McAllen dia nahita fotoana mety sy loza mampangataka. Nianatra nanome tanana izy, nitondra entana mafy mivantana an’i sisintany. Maro amin’ny namana tsara indrindra dia maty na an-tranomaizina noho ireo loza ireo. Nahazo loza rehetra i izy. Tamin’ny 16 taona, tsy maintsy niala tanteraka izy .

Na dia nisy loza aza, dia tsy niakatra lalana maloto toy ny fanomezana zavatra hafa izy. Nifantoka tamin’ny kannabis izy, nahita fa azo antoka sy maharitra kokoa. Nitombo tamin’ny tontolo kannabis talohan’ny legalisation izy, nianatra ny zava-maniry akaiky mandritra ny niasana. Tamin’ny fotoana, dia niova tamin’ny asa mampidi-doza ho amin’ny orinasa ara-dalàna izay mino izy .

Taorian’ny, dia lasa injeniera software voafehy i Colin ary nanao asa fampandrosoana ho an’ny Baylor College of Medicine – iray amin’ireo fikambanana ara-pahasalamana lehibe indrindra any Texas Medical Center. Ity fifangaroana – fahalalana lalina momba ny kannabis sy ny fanjakazakan’ny fahasalamana – no manome ny fomba fiasan’i OilWell .

Bentley: Ny Alika Nanomboka Ny Zava-Drehetra

Ny tantaran’ny orinasa dia nanomboka tamin’ny alika antsoina hoe Bentley. Bentley dia fianakaviana, namana niaraka tamin’i Colin tamin’ny fotoana sarotra indrindra. Rehefa marary be i Bentley, dia nanome fanapahan-kevitra ny dokotera amin’ny biby: ny euthanasia ihany no safidy. Tsy mahazaka ny tongotra aoriana i Bentley. Nilaza izy ireo fa ny fitsaboana fanaintainana dia hamono ny ati-bavy, hiteraka faharatsiana kokoa. Ny safidy dia fahalavoana maharitra na famonoana haingana .

Fa tsy safidy ny misy. Nalaza tamin’ny alalan’ny fanontaniana iray izay nanova ny zava-drehetra i Colin tamin’ny fikarohana alternatives. Namangy mpanao fanampiana biby antsoina hoe Jessica izay nanontany: “Nitondra tondra-marina be ianao nefa tsy mbola re foie CBD?” Nanao traikefa tamin’ny kannabis i Colin – fa tsy fotsiny hoe fahafinaretana. Ny fanontaniana an’i Jessica dia nanome toe-javatra vaovao izay lasa tanjona .

Nanao paste gold CBD i Colin mba hamonjy an’i Bentley – formula cannabinoid manokana ho an’ny biby. Ny fanantenana izay nahavita izay tsy azon’ny fitsaboana mahazatra: niaraka i Bentley, nidina tamin’ny tongony. Tany paralyzed sy euthanasia, ka lasa nitondra baolina hilalao. Tsy placebo izany – tsy mahatsapa placebo ny alika. Io dia fahasalamana cannabinoid nanome izay tsy azon’ny fitsaboana .

Nijanona 10 taona i Bentley, maty fahiny tamin’ny 20 taona. Mandritra ireo taona ireo, dia nanao formula cannabinoid manokana i Colin ho an’ny toe-javatra isan-taona i Bentley. Neurodegeneration dia nanome azy fahalalana momba ny CBG sy THCa PPARγ agonism ho an’ny fiarovana cell cerveau. Dementia dia nanome azy fahalalana momba ny anjaran’ny CBC amin’ny neurogenesis. Glaucoma dia nanome fahalalana momba ny THC CB1 agonism ho an’ny fanakana pressure intraocular. Osteoarthritis dia nanome fomba multi-pathway anti-inflammatory mampiasa CBD, CBG, THCa, ary beta-caryophyllene miasa amin’ny receptor system samihafa .

Tsy ampy ny cannabinoids tokana. Ny toe-javatra an’i Bentley dia nanampy formula multi-cannabinoid. Tsy ampy ny CBD irery hamahana neurodegeneration sy dementia sy glaucoma sy osteoarthritis. Nisy ny cannabinoids kely toy ny CBG, CBN, ary CBC ho an’ny zava-dehibe rehefa nihaona i Bentley. Ny fanjakazakan’ny fitsaboana dia manan-danja – ny fiainan’i Bentley dia miankina amin’ny accuracy formula, fa tsy guesswork .

Ny dian’i Bentley no nampidirana an’i Colin tamin’ny kannabis afa-tsy fahafinaretana. Las tanjona nanao vaha-mahomby tena izay mampihena fanaintainaina sy fahoriana – fa tsy ho an’ny biby fotsiny fa ho an’ny olona. Ny tantaran’i Bentley no fototra OilWell, mampiroborobo ny fahatokisantsika amin’ny kalitao, inovation, ary fikarakarana miaraka amin’ny hatsaram-panahy .

Ny Dalan’i Colin: PTSD, Fahadisoana Benzo, sy Peace Gummies

Fantatran’i Colin ny fiankinan-doha amin’ny fitsaboana. Niady tamin’ny PTSD sy ny fahadisoana benzodiazepine izy. Rehefa nieritreritra hiala tamin’ny Xanax izy, dia nanao azy cold turkey – zava-dehibe sy mampidi-doza – mampiasa ny fahalalana cannabinoid nataony hamonjy an’i Bentley. Ny formula Peace Gummies izay lasa vokatra OilWell dia natao tamin’ny fampiratiana tamin’ny alina mandritra ny fahaleovantena benzo. Mba hanomezana fanamaivanana haingana, manome Peace Gummies amin’ny endrika vape ihany koa i OilWell, izay ampiasain’i Colin manokana mba hanaraha-maso ny insomnia sy PTSD mafy mandritra ny fotoana. Tsy fahalalana teôria izany. Niaina i Colin izay niainan’ny marary RSO: fahoriana noho ny fanaintainana, fitsaboana tsy nahomby, ny fahitana fa mahomby ny cannabinoid rehefa tsy mahomby ny pilina .

Tamin’ny fotoana, dia lasa fototra ny tombony terapeutika hitan’i Colin tamin’i Bentley. Nanao formula izy izay ampiasain’ny dokotera ho an’ny Crohn’s disease, IBS, ulcerative colitis, PTSD, fahadisoana benzo, ary insomnia. Ny fahatokisany dia nanome kannabis mora sy mahomby ho an’ny rehetra, anisan’ny vegans, diabetics, sy ireo misy filàra-pahasalamana manokana .

Fahazoana Media ABC13: Fitory Fampisehoana, Efatra Taona, Tokana Iraisam-pirenena

Manomboka Septambra 2019 ka hatramin’ny Aprily 2023, ny ABC13 Houston (KTRK) – ny affiliate ABC mpanome serivisy amin’ny tanàna lehibe indrindra fahefatra Amerika – dia nampiseho Colin Valencia sy ny OilWell Cannabis tamin’ny fito fizarana samihafa momba ny orinasa, lalàna, fitsaboana, fahasalamana vondrona, ary politika. Dimy mpanao gazety samihafa no nitady azy: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, ary mpanao gazety KTRK. Tsy misy mpamatsy kannabis Houston hafa hita amin’ny frequency sy halalin’izany .

Ity rakitra media ity dia tsy marketing. Fampisehoana independent news coverage izay natao tamin’ny fomba editorial. Ho an’ny mpanoratra any Madagasikara manamarina raha mety i OilWell, io fanamarinana io avy amin’ny ABC affiliate lehibe dia manome fahatokisana tsy azo omen’ny tenenosana .

Fampisehoana 1: Orinasa CBD Texas manjaka — 15 Septambra 2019
Mpanao gazety Tom Abrahams dia nanoratra momba ny OilWell ho mpamatsy an-tanàna. Ny fehezanteny fototra nataon’i Colin: “Tsy te hiolaka aho. Tsy te hanome fanantenana aho, fa misy fikarohana ampy izay mila fantatry ny olona sy andramana ary manana ny version tsara indrindra mba hahatonga ny hevitry ny olona mba hahafahana manao izay mety sy tsy mety azy.” Io fehezanteny io no maneho ny filozofintsika. Tonga taona maro alohan’ny namoahana ireo formula ireo, mampiseho ny fahatongavantsika .

Fampisehoana 2: Mpamorona orinasa mivantana any amin’ny mpanjifa — 22 Martsa 2021
Niverina i Tom Abrahams raha nitonona an’i Colin nanampy mpamorona hafa toy ny Jonathan Hanomboka High Maintenance Edibles. Ny fehezanteny therapy-n’i Colin – “Misy karazana fanaintainaina maro” – dia nankatoa ny dimension therapeutic, mifanaraka amin’ny fahoriana maro any Madagasikara .

Fampisehoana 3: Inona no Delta 8 THC — 24 Mey 2021
Fampisehoana fikarohana an’i Steve Campion dia nampiseho ny fifanakalozan-kevitra malaza: “Mety te ho high ianao.” Fahamarinana radicals amin’ny TV mahazatra. Ny singa dia mampitaha ny hevitry ny Colin sy ny fahatongavan’i Dr. Michael Weaver sy ny fanentanana reglementaire an’i Heather Fazio, plus ny fanambaran’ny DEA momba ny tsy fahatokisan’ny delta-8 .

Fampisehoana 4: Magazena CBD Houston manome vokatra maimaim-poana ho an’ny vaccine COVID — 20 Aogositra 2021
Mpanao gazety KTRK dia nanoratra momba ny fikarakarana fahasalamana vondrona lehibe indrindra nataon’i OilWell: 1.000 caviar pre-rolls manokana, eo amin’ny $35.000 amin’ny vokatra, nomena mba hamporisika ny vaccine. Ny fanomezana tao HydroShack Hydroponics dia niarahana tamin’ny tanànan’i Houston. Ny Instagram OilWell dia nilaza: “Te ho salama indrindra i Houston. Tsy izahay dokotera. Tsy manan-danja momba io izahay. Tsy misy politika. Avia raha mety sy azo antoka ho anao sy ny tianao!” Io dia hetsika voamarina, fa tsy marketing .

Fampisehoana 5: Fisakanana Texas momba ny Delta 8 tsy ara-dalàna — 19 Oktobra 2021
Shelley Childers dia nahita fa nanala ny vokatra Delta-8 i Colin alohan’ny nanombohan’ny fanenjehana sy nampitandrina mpamatsy hafa izay tsy fantany fa nandefa Schedule I narcotics. Tsy nahazo vola be izy mba handroso. Zachary Maxwell avy amin’ny Texas Hemp Growers dia nanome context: miaramila miaraka amin’ny PTSD, $50 tapitrisa market Texas, sazy felony ho an’ny vape cartridge iray. Texas DSHS dia nilaza fa “efa tsy ara-dalàna” ny delta-8 nefa tsy fantany ny fomba niainan’ny market .

Fampisehoana 6: Fanafahana marijuana Biden — 7 Oktobra 2022
Nick Natario dia nahita ny tantara manokanan’i Colin momba ny fitsarana marijuana. Ny lahatsoratra dia nanomboka tamin’ny vending machine CBD OilWell, avy eo nilaza i Colin: “Misy olana amin’ny trano, loans, banking, zava-drehetra.” Nanampy: “Tiako ho hita fa tsy misy olona hanimba amin’io intsony.” Ity fanambarana manokana ity dia manova ny fehezanteny rehetra – tsy mpiasa orinasa ivelany i Colin fa olona niaina ny vokany .

Fampisehoana 7: Indostria marijuana manao fanao vaovao — 21 Aprily 2023
Nick Natario dia nampiseho Colin manan-janafana hemp: “Izao fotoana izao dia… toy ny Renaissance – tokony homena lanja izao.” Nico Richardson dia mampitaha Texas (10.000 marary medical marijuana) amin’i Florida (700.000 marary na dia roa-telon’ny mponina). Ny singa dia nanaraka ny fahatongavan’ny HB1805 sy $3,7 lavitrisa dolara tany amin’ny hetra avy amin’ny states legal .

Ny Lalan’ny Fahatongavana: Inona Ny Fitopolo Taona Media Coverage dia Maneho

Fahatongavana mandritra ny taona. Manomboka 2019 ka hatramin’ny 2023, mandritra ny fiovana rehetra, dia miverina amin’i Colin i ABC13 ho loharano fototra. Any Madagasikara, izay mety kely na sensationalized ny media coverage momba ny kannabis, io journalism maharitra io dia manome fahatokisana .

Hahalalana lalina. Ny fampisehoana dia manome sakafo momba ny orinasa, fahasalamana mpanjifa, analysis legal, commentary politika, ary fanentanana vondrona. Tsy misy olona Houston hafa niteny tamin’io halalin’io .

Fikarakarana vondrona. Ny fanomezana vaccine $35.000 sy ny fanalana delta-8 dia manome filozofia vondrona-voalohany. Ho an’i Madagasikara, izay ny fihavanana vondrona dia fototra ara-kolontsaina, ireo hetsika ireo dia mifanaraka .

Resaka manokana. Ny tantaran’ny fitsarana manokan’i Colin dia manome hery ny fampisehoana rehetra. Tsy spokesperson corporate izy – fa olona niaina ny vokany .

Fivoarana ny fiteny. Avy amin’ny “mpamatsy an-tanàna” ho “autorité de l’industrie” ka hatramin’ny “Renaissance”, ny media record dia maneho fahatongavana. Ho an’ny mpanoratra any Madagasikara manamarina orinasa Houston, io dia manome hery .

Ireo fampisehoana ireo dia tsy azo vidiana – fa azo tazana. Ho an’ny mpanjifa any Madagasikara manahy momba ny scam an-tserasera, io fanamarinana voamarina io dia manome famantarana fahatokisana tsy azo omena marketing.

Filozofia OilWell RSO: Fefy Fototra Efatra Ho An’i Madagasikara

1. Fahazoana vs fanaraha-maso. Tsy mila carte medicale. 21+ fotsiny. Manome an-tanàna manerana Etazonia sy maneran-tany izahay amin’ny mpanjifa manamarina ny legalité any an-toerany. Simpson mino fa tokony ho azo antoka ny fitsaboana; nanao modely vokatra sy fizarana izay manome azy ara-dalàna izahay – na any Madagasikara aza, izay mety kely ny fahazoana kannabis medical .

2. Fahafahana ara-pahasalamana. Ny THCa dia amidy amin’ny endrika acidic, non-psychoactive. Mpanapaka ianao raha ampiasaina mody ho an’ny tombony non-psychoactive na decarboxylated ho delta-9 THC – hery tanteraka. Ho an’ny professionals Malagasy miasa, mandeha, na ray aman-dreny, io fanaraha-maso io dia tena manan-danja .

3. Formulas open-source. Mamoaka formulas feno an-tserasera izahay – tsirairay cannabinoid, tsirairay milligramme, tsirairay percentage – mba ahafahan’ny olona izay tsy afaka hividy ny vokatra mba hahazoana singa sy manao azy. Simpson nanome solika maimaim-poana sy mampianatra; nampifanaraka io filozofia io ho an’ny tsena kannabinoid maoderina izahay .

4. Mifototra amin’ny fanamarinana, fa tsy mihoatra. Ny GENERAL KNOWLEDGE section dia maneho ny fanentanantsika amin’ny fampianarana marina momba ny siansa. Simpson niara-niasa tsy misy fidirana amin’ny literatura voamarina; manana io fidirana io izahay ary mampiasa azy mba hisarahana ny fanentanana voafehy, mitombo, sy be loatra .

Fanekena Farm Bill sy Ny Framework Legal THCa Ho An’i Madagasikara

Ny Farm Bill 2018 dia nanome legalité ny hemp sy ny vokatra hemp-derived misy kely kokoa noho ny 0,3% delta-9 THC amin’ny lanja sika amin’ny tany federal. Io no fototra legalin’ny vokatraintsika.

Ny RSO Sublingual Oil OilWell dia manome delta-9 THC 90 mg fotsiny ao amin’ny banga 30 mL – 3 mg/mL – latsaky ny 0,3% threshold. Hemp-derived avokoa ny cannabinoids rehetra. Ara-dalàna federal sy amin’ny ankamaroan’ny states io.

Ny THCa no fototra. Ny THCa dia precursor acidic, non-psychoactive amin’ny delta-9 THC. Tsy delta-9 THC mihitsy izy. Io dia manan-danja legal: THCa dia Farm Bill compliant amin’ny fotoana fividianana satria tsy mbola niova ho delta-9 THC.

Fahatongavan’ny ankapobeny ho an’i Madagasikara: Azonao vidiana sy ananana ara-dalàna io vokatra io. Raha safidy ny manova ny THCa ho delta-9 THC any an-trano (260°F mandritra ny 45-60 minitra), dia mitranga io conversion io amin’ny tsirony ianao aorian’ny fividianana. Midika izany fa ny vokatra iray ihany dia afaka miasa anti-inflammatory non-psychoactive NA cannabinoid medicine psychoactive hery tanteraka – safidy anao tanteraka.

Fampandrenesiana legal manan-danja ho an’ny mpanjifa any Madagasikara: Mety miova ho delta-9 THC ny THCa rehefa hafanana. Tompon’andraikitra ianao amin’ny fahalalana sy fanekena ny lalànan’i Madagasikara momba ny vokatra hemp. Manome documentation feno, Certificates of Analysis, sy receipts izahay. Mpanjifa iraisam-pirenena dia miaina ny risika rehetra momba ny douane sy ny lalàna. Tokony hojerena aloha ny fitsipika manokana an’i Madagasikara momba ny vokatra hemp-derived alohan’ny mividy.

Formulas Open-Source: Nahoana Izahay Mamoaka Zava-Drehetra

Mamoaka formulas RSO feno an-tserasera izahay – tsirairay cannabinoid, tsirairay milligramme, tsirairay percentage – mba ahafahan’ny olona izay tsy afaka hividy ny vokatra mba hahita lalina ny zava-misy, maka ny distillates sy isolates cannabinoid, ary manao ny version nataony. Ny formulas ao amin’ny antontan-taratasy dia ny recipes open-source .

Maneho ny hevitry’i Rick Simpson io. Nanome solika maimaim-poana sy mampianatra izy, tsy nanome patent, tsy nanan-ketra. Nampifanaraka io filozofia io izahay: mivarotra vokatra voafehy, voamarina, voafehy ho an’ny te-hahazo, ary mamoaka ny recipe feno ho an’ny te-manao .

Ny filozofintsika, araka ny nilazany tamin’i ABC13 tamin’ny 2019: “Tsy te hiolaka aho. Tsy te hanome fanantenana aho, fa misy fikarohana ampy izay mila fantatry ny olona sy andramana ary manana ny version tsara indrindra mba hahatonga ny hevitry ny olona mba hahafahana manao izay mety sy tsy mety azy.”

Ny formula open-source fototra: paste gold CBD ho an’ny biby. Alohan’ny namoahana ny formulas RSO, dia namoaka ny recipe paste gold CBD tena izay nanavotra an’i Bentley izahay, mba ahafahana ny tompon-biby manana olana mitovy manao azy:

• 1/2 cup turmeric powder organique
• 1 cup rano
• 1/3 cup solika coconut (tsy voafehy, organique)
• 1-2 teaspoons dipoavatra mainty vaovao (manan-danja ho an’ny absorption)
• Solika CBD ( dosage miankina amin’ny haben’ny biby; mifandraisa amin’ny dokotera amin’ny biby)

Ataovy paste turmeric sy rano amin’ny hafanana ambany mandritra ny 7-10 minitra. Ampio solika coconut sy dipoavatra. Avelao mandainga ary aorina mandritra ny herinandro roa. Mix amin’ny sakafo biby indray mandeuva na roa indray andro. Ity recipe ity – navoaka maimaim-poana, taona maro alohan’ny formulas RSO – dia maneho fa ny open-source dia fototra fomba fiasa, fa tsy strategy marketing .

Famokarana Tsy Misy Solvent: Fahasalamana Tsy Misy Fahalemena

Ny RSO-tsika dia tsy vokatra fanalana. Misy fangaro voafehy amin’ny distillates sy isolates cannabinoid misy dosage mazava ao amin’ny tontolo famokarana voafehy. Tsy misy naphtha. Tsy misy alikaola isopropyl. Tsy misy butane. Tsy misy solvent fanalana amin’ny vokatra farany .

Io dia manala ny risika solvent sisa izay iray amin’ny fiarovana lehibe indrindra – manan-danja ho an’ny mpanjifa any Madagasikara izay mety tsy misy fidirana amin’ny fanandramana laboratory mba hamaritana ny fahasalamana vokatra.

Mampiasa solika MCT organique (medium-chain triglycerides) izahay ho an’ny carrier. Ny solika MCT dia lipid food-grade izay manampy amin’ny absorption sublingual sy manome taste neutral – fanatsarana lehibe amin’ny consistency tar-like sy odor solvent sisan’ny RSO taloha .

Ny fanandramana laboratory third-party dia manome potency cannabinoid, profile terpene, sy panels fiarovana anisan’ny pesticides, metaly mavesatra, solvent sisa, ary contaminants microbial. Ny Certificates of Analysis (COAs) dia misy amin’ny fangatahana sy azo alaina amin’ny tranokalantsika. Ho an’ny mpanjifa any Madagasikara, io transparency io dia tena manan-danja – tsirairay lot dia voamarina, tsy guesswork.

Fandefasana sy Fahazoana Ireran-tany: Fomba Fahazoana OilWell RSO Any Madagasikara

Manome serivisy delivery RSO androany ihany any Houston izahay, fa ny fahafahantsika dia mihoatra lavitra Texas. Ho an’i Madagasikara, izao no manan-danja:

Fandefasana iraisam-pirenena any Madagasikara: Mandefa iraisam-pirenena izahay sy efa nanome vokatra any firenena maro maneran-tany. Ny framework legal THCa dia manome izany: satria vokatra hemp-derived misy kely kokoa noho ny 0,3% delta-9 THC amin’ny fividianana, dia mifanaraka amin’ny famaritana ny vokatra hemp ao amin’ny Farm Bill 2018 ary azo entina any amin’ny toerana misy lalàna hemp mifanaraka.

• Ny fonosana rehetra dia manome documentation feno, Certificates of Analysis, ary receipts ho an’ny douane Madagasikara
• Misotroa shipping minimum; raha be loatra ny shipping iraisam-pirenena dia apetraka amin’ny mpanjifa
• Tompon’andraikitra i amin’ny fanamarina ny legalité any Madagasikara ary miaina ny risika rehetra momba ny douane sy ny lalàna
• Mifandraisa: (832) 416-2816 na [email protected]

Tecknologie PANDEM1C SEO: Ny rafitra manokana anay miaraka amin’ny 14 tapitrisa toerana geopolitique ao amin’ny database-ny sy 300+ modèles AI dia manome visibility organique maneran-tany, mahatonga ny vokatra OilWell ho hita eo amin’ny marary Madagasikara mitady RSO amin’ny teny Anglisy na Malagasy.

Ny fisian’izany: Tsy afaka naniraka solikany i Rick Simpson na aiza na aiza – Schedule I izy, tsy ara-dalàna ny famokarana, fitandremana, na fitaterana. Afaka mahazo formula multi-cannabinoid clinical-strength RSO ihany ankehitriny ny marary kanserô any Antananarivo, marary faharatsiana maharitra any Toamasina, na miaramila any Antsiranana – mitovy amin’ny Houston resident mahazo delivery androany. Nanao vokatra azo mandroso amin’ny sisintany ara-dalàna izahay – mampahomby ny fahitry’i Simpson izay tsy azo natao noho ny fisakanana .

Solika Sublingual OilWell RSO: Ny Formula Feno

Ity no formula sublingual open-source anay. Ny tsirairay milligramme dia navoaka – vokatra specification, outil éducatif, ary recipe ho an’ny mpanao DIY any Madagasikara.

Cannabinoid	Amount
CBD	4.500 mg
CBG	3.000 mg
Delta-8 THC	6.000 mg
THCa	1.500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16.590 mg

• Terpenes Velona: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Endrika: Banger 30 mL (1 fl oz)
• Cannabinoids mavitrika isaky ny mL: 553 mg
• Carrier: Solika MCT organique
• Outil dosage: Dropper mazava amin’ny increments 0,1 mL
• Onset: 15-45 minitra (absorption sublingual)
• Peak effects: 1-2 ora
• Duration: 4-6 ora
• Bioavailability: 13-19% (mandroso tsy amin’ny first-pass liver)
• Doses per banga: ~40-60 miankina amin’ny habetsahan’ny serivisy
• Vidiny: $129,99

Ho an’ny mpanjifa any Madagasikara, izao no dikany: 553 mg cannabinoids mavitrika amin’ny millilitre tsirairay – mazava, azo izarana, ary mitovy. Tsy misy guesswork.

Cartridge Vape OilWell RSO: Ny Formula Feno

Ny formula vape dia mampiasa percentages fa tsy mg (cartridge 1 grama). Cannabinoids enina (tsy misy delta-9 THC voalaza – THCa auto-decarbs amin’ny hafanana vaping).

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Terpenes Velona: 5%+
• Endrika: Cartridge 1 grama
• Fahamafin’ny battery: 510-thread universel
• Onset: 1-2 minitra (fandefasana haingana indrindra)
• Peak effects: 10-15 minitra
• Duration: 2-4 ora
• Bioavailability: 10-35% (miankina amin’ny fomba fihinana)
• Auto decarboxylation THCa: Amin’ny hafanana vaping (400-450°F)
• Vidiny: $49,99

Ho an’ny mpanjifa any Madagasikara mila fanamaivanana haingana – fanaintainaina breakthrough, ataque de panique, nausea – ny onset 1-2 minitr’ilay vape dia tsy misy mitovy.

Profile Terpene: Lafy Sensory sy Biologique

Ny vokatra roa dia manome profile fitopolo terpenes:

• Limonene (voasary mazava): Monoterpene multifunctional miaraka amin’ny antioxidant, anti-inflammatory, cardioprotecteur, gastroprotecteur – saingy most evidence preclinical [21]. Fanamarihana fiarovana: oxidation products limonene dia allergens [22].

• Myrcene: Anxiolytique, antioxidant, anti-inflammatory, analgesic amin’ny modèles preclinical – evidence olombelona voafetra [23]. Matetika lazaina sedative, fa mihoatra ny fanamarinana olombelona ankehitriny [20][23].

• Caryophyllene (β-caryophyllene, dipoavatra/poivre): Agoniste CB2 receptor selectif – manan-danja pharmacologically. Anti-inflammatory, immunomodulateur, antioxidant, neuroprotecteur, gastroprotecteur – confirmation olombelona voafetra [24]. Ity no terpene mahery indrindra amin’ny cannabinoid system.

• Pinene (foret frais): Signals antioxidant, anti-inflammatory, neuroprotecteur – fa trials olombelona tsy ampy [25]. Ny fanambarana momba ny fanatsarana ny fahatsiarovana na fanalana ny vokatry ny THC dia hypotheses [20][25].

• Linalool (floral, lavandera): Pharmacologie stress, mood, ary sante cerveau – fa evidence preclinical. Oxidized linalool hydroperoxides dia allergens [22][25][26].

• Humulene (terreux, boisé): Evidence preclinical momba ny anti-inflammatory sy cannabimimetic – hypothesis-generating [27].

• Terpinolene (pin, fruité): Evidence base voafehy amin’ny in silico, in vitro, animal studies – terpene kely indrindra [28].

Ho an’ny mpanjifa any Madagasikara, ireo aromas ireo dia mety mifandray amin’ny zavamaniry mahazatra – voasary avy amin’ny morondrano, scents foret avy amin’ny faritra ambony, dipoavatra sy spices avy amin’ny sakafo Malagasy. Ny dimension sensory dia mahatonga ny traikefa vokatra ho fahafinaretana, fa tsy fitsaboana fotsiny.

Contexte Fampiasana Mifototra amin’ny Toe-Javatra Ho An’i Madagasikara

Fanamarihana manan-danja: Ireo contexts ireo dia voafintina amin’ny fikarohana cannabinoid sited amin’ny GENERAL KNOWLEDGE sy ny famahavan’ny formulation. Tsy torohevitra ara-pahasalamana, tsy protocol FDA, ary tsy safidy amin’ny fitsaboana mahazatra. Tsy voasokajin’ny Food and Drug Administration ireo vokatra ireo ary tsy tanjona hamantarana, manasitrana, na manala aretina. Mifandraisa amin’ny mpiasan’ny fahasalamana voafehy alohan’ny hampiasana vokatra cannabinoid, indrindra raha manana toe-javatra, misy fitsaboana, bevohoka na mpanjaka, na manana olana ara-pahasalamana. Aza mandeha fiara na milina rehefa under influence cannabinoids psychoactive.

Fomba fijerena manokana ho an’i Madagasikara: Raha mandeha fitsaboana any amin’ny toerana any Antananarivo na Toamasina, na mifandraisa amin’ny mpitsabo tradisionaly any ambanivohitra, dia resaho momba ny fampiasana cannabinoid amin’ny mpiasanao. Misy fahasarotana amin’ny rafitra ara-pahasalamana any Madagasikara; ny fampidirana cannabinoid dia tokony hanampy, fa tsy hanoloana ny fitsaboana voamarina.

Fanafangana chemo sy fanohanana sakafo (ho an’ny marary kanserô any Madagasikara mahazo fitsaboana any Antananarivo na any ivelany):

• Amin’ny alohan’ny chemo: 0,5-1,0 mL sublingual ~1 ora alohan’ny fitsaboana
• Nausea breakthrough haingana: 2-3 vape puffs ho an’ny fanamaivanana haingana (onset 1-2 minitra)
• Aorian’ny chemo: 0,5 mL sublingual isaky 6 ora raha ilaina
• Fanohanana torimaso mandritra ny fitsaboana: 1,0-2,0 mL sublingual alohan’ny torimaso (manome 25-50 mg CBN)
• Fanamarinana: Anti-emetic delta-8 THC [9], nausea/vomiting delta-9 THC [1][13], buffering anxiolytic CBD [3]

Faharatsiana maharitra (fibromyalgia, osteoarthritis, neuropathy – mahazatra any amin’ny mpamboly Malagasy mahatratra ny taona):

• Andavanandro: 0,3-0,5 mL sublingual mody – anti-inflammatory tsy misy psychoactive ho an’ny mpamboly
• Alina: 0,5-1,0 mL sublingual decarboxylated – fandriam-pahalemana miaraka amin’ny fanohanana torimaso CBN
• Breakthrough: Vape raha ilaina
• Fanamarinana: Fahoriana CBD [4], delta-9 THC [13], agonism CB2 beta-caryophyllene [24], inhibition COX-2 THCa [12]

Fanohanana torimaso (ho an’ny mpiasa Malagasy miara-miasa, mpikarakara, na olona misy insomnia noho ny stress):

• Amin’ny alohan’ny torimaso: 1,0-2,0 mL sublingual
• Amin’ny 2,0 mL: 50 mg CBN – dosage voalaza tamin’ny literatura torimaso 2024
• Amin’ny 1,0 mL: 25 mg CBN – ambony noho ny threshold mampihena fahasarotana torimaso [16][17]
• Fanamarinana: Torimaso CBN [16][17], review torimaso kannabis

Fahatakarana sy stress (ho an’ny professionals, mpianatra, na olona manana trauma Malagasy):

• Relief andavanandro: 0,3 mL sublingual mody – CBD sy CBG manome anti-anxiety tsy misy intoxication
• Alina: 1,0 mL sublingual – profile feno miaraka amin’ny CBN ho an’ny sleep architecture
• Fanamarinana: Anxiety CBD [3], pharmacologie CBG [7][8], entourage limonene [20]

Fomba titration ankapobeny ho an’i Madagasikara: Start low, go slow. Manomboka amin’ny 0,25-0,5 mL sublingual ary jerena ny vokatra mandritra ny 2-3 ora alohan’ny manampy. Samihafa ny valin-kafan’ny olona miankina amin’ny lanja, metabolism, fahazaran-dalàna, fitsaboana miaraka, ary zava-kotrana.

Nahoana Ny Tontolo Fahasalamana Madagasikara Dia Maneho Ity

Misy fanamby lehibe momba ny fahasalamana any Madagasikara: fidirana kely amin’ny specialist any ambanivohitra, halavirana lava any amin’ny toerana urban toy ny Antananarivo, ary fahazoana fitsaboana fanafangana sy fanohanana kanserô miovaova. Ho an’ny marary Malagasy lazaina fa “tsy misy safidy intsony”, ny fampahafantarana cannabinoid dia manome fanantenana mifototra amin’ny siansa, fa tsy fahadisoam-panantenana.

Ny fomba fiasan’ny open-source dia manan-danja manokana amin’ny context ekonomikan’i Madagasikara. Raha $129,99 dia mihoatra ny fahafahana, dia maimaim-poana ny formula. Afaka maka ny singa sy manao ny version natao ianao. Tsy fitiavana – fa fahafahana .

Mifandraisa Aminay: Fahazoany Madagasikara

Asa any Houston: 810 Richmond Avenue, Houston, TX 77006 (fiainana Montrose). Miasa hatramin’ny 2019, ~$1M taom-bola, Google rating ~5,0, licensi Texas DSHS. Ny artwork, formulae, sy packaging rehetra dia natao an-tanana .

Ho an’ny mpanjifa any Madagasikara:

• Telefaonina: (832) 416-2816
• Email: [email protected]
• Tranokala: https://oilwellcbd.com/
• Instagram: @oilwellcbd

Fividiana avy any Madagasikara:

1. Hamarino ny lalànan’i Madagasikara momba ny import vokatra hemp
2. Mifandraisa momba ny vidin’ny shipping sy documentation
3. Manome COAs, receipts, ary paper douane izahay
4. Mividy an-tserasera na amin’ny alalan’ny telefaona/email
5. Ekena ny delivery sy ny andraikitra rehetra momba ny douane

Delivery androany any Houston dia maimaim-poana any Texas Medical Center (lehibe indrindra eran-tany), $5-25 manerana Houston. Ho an’i Madagasikara, ny shipping iraisam-pirenena dia manome precision Houston any an-tranonao .

General Knowledge: Ny Siansa Manohy Ny Tsirairay

Fomba Fikarohana sy Ny Fanekena Ny Fanamarin

Manome lanja ny loharano amin’io laharana io: fanamarinana ara-tsiansa olombelona, avy eo review sy meta-analyses, avy eo famintinana NIH, avy eo literatura preclinical sy mechanistic rehefa misy data olombelona kely. Io dia manan-danja satria tsy mitovy ny base evidence. CBD sy delta-9 THC manana literatura olombelona matanjaka indrindra; delta-8 THC, THCa, CBG, CBN, CBC, sy ny ankamaroan’ny terpenes dia mifototra kokoa amin’ny review, travail akena, sy literatura preclinical [1]-[29].

Tanjona Fototra Avy Amin’ny NIH Sy Loharano Mifandraika

• NCCIH milaza: Ny fanamarinana cannabinoid matanjaka indrindra dia ho an’ny epilepsia kely, nausea/vomitation chemo, sy famahana HIV/AIDS. Evidence tsy ampy ho an’ny aretina hafa [1].
• FDA dia tsy nanome fanekena amin’ny vokatra kannabis rehetra. Epidiolex (CBD) ho an’ny seizures sy analogues THC synthétique ho an’ny nausea chemo sy famahana AIDS fotsiny no voafehy [1].
• Fiarovana: Fahakiviana, risika accidents, cannabis use disorder, olana amin’ny bevohoka, exposure accidentelle ankizy, contamination, vape-related lung injury [1].
• Risika CBD: Fahakiviana, effects gastrointestinal, olana amin’ny liver, interactions medicamenteuses [1][6].

Profiles Cannabinoid

CBD: Fanamarinana olombelona matanjaka indrindra amin’ny disorders fanaintainaina [1][2]. Anxiety: review 2024 avy amin’ny 316 participants dia nahita signal anxiolytique significant fa kely sample [3]. Pain: review 2024 dia nahita heterogeneous fa kely trials [4]. Torimaso: review 2023 dia nahita literature faible méthodologiquement [5]. Sécurité: review 2023 dia nahita signal liver enzyme elevation, manan-danja amin’ny produits concentrés oraux [6].

CBG: Review sy preclinical; evidence olombelona kely [7][8]. Pharmacologie samihafa amin’ny THC sy CBD, mifandray amin’ny receptors cannabinoid, alpha-2 adrenoceptors, sy signalisation 5-HT1A – mechanistically manan-danja fa tsy clinically établie [7]. Possible neurologic, IBD, antibacterial – preclinical [7][8]. Vendu commercialement nefa base evidence faible [7].

Delta-8 THC: Pharmacologiquement psychoactive, moins caractérisée que delta-9 [9]-[11]. Review 2022: delta-8 sy delta-9 dia mitovy pharmacokinetic/pharmacodynamic; delta-8 dia agoniste CB1 partiel, moins puissant [9]. Review 2023 dia nahita base evidence dominée par animal, chimie, rapports d’usage, concerns santé publique [10]. Intérêt commercial: stabilité, synthèse facile [11]. Psychoactive, similarité delta-9, manque de données sécurité humaine [9]-[11].

THCa: Chimiquement important, fa evidence thérapeutique humaine faible [12]. THCa tsy psychoactive, fa conversion dépend de la route, température, traitement, stockage [12]. In vitro sy akena: anti-inflammatory, immunomodulateur, neuroprotecteur, antinéoplasique – tsy équivalent aux résultats humains [12].

Delta-9 THC: Evidence humaine la plus forte, mais effets indésirables clairs [1][13]-[15]. NCCIH: nausea/vomitation chemo, appétit/amaigrissement VIH/SIDA, symptômes SEP/douleur – fa tsy certain [1]. Review 2022 douleur chronique: haut-THC dia peut-être bénéfice à court terme fa manome dizziness, sedation, nausea [13]. Pharmacocinétique classique: inhalation rapide, oral retardé [14]. Review 2025 produits haute concentration: associations défavorables psychose/schizophrénie, cannabis use disorder [15]. Risques: anxiété/panique, tachycardie, hypotension, dépendance [1][14][15].

CBN: Evidence humaine faible; marketing a dépassé les données [12][16][17]. Réputation sommeil/sédation répandue, mais support clinique bien plus faible que le marché ne le suggère [16][17]. Review 2021: pas d’essais cliniques utilisant des questionnaires validés ou polysomnographie [16]. Review 2024: besoin d’essais mieux conçus [17].

CBC: Émergent, préclinique [18][19]. Review 2024: pharmacodynamique distincte, cibles intéressantes – antinociceptif, antibactérien, anti-convulsif, mais confirmation clinique humaine limitée [18]. Review plus ancienne: anti-inflammatoire, effet analgésique modeste chez le rodent – pas preuve forte [19]. Produits déjà vendus malgré peu de preuves [18].

Profiles Terpene

Limonene: Review/préclinique; 2021: antioxidant, anti-inflammatoire, cardioprotecteur, gastroprotecteur – mais majorité preuve non humaine [21]. Sécurité: produits d’oxydation limonène sont des allergens [22].

Myrcene: Préclinique, très peu de preuve humaine [20][23]. 2021: anxiolytique, anti-inflammatoire, analgésique – mais études humaines manquantes [23]. Affirmation sédative dépasse preuve humaine [20][23].

Caryophyllene: Le plus intéressant mécanistiquement (agoniste CB2) mais préclinique [24]. 2021: anti-inflammatoire, immunomodulateur, neuroprotecteur – confirmation clinique humaine limitée [24].

Pinene: Prometteur préclinique, preuve clinique humaine faible [20][25]. 2021: antioxidant, anti-inflammatoire, neuroprotecteur justifient études futures – essais bien conçus manquants [25]. Affirmations mémoire/attention dépassent preuve [20][25].

Linalool: Grand intérêt préclinique, confirmation clinique directe limitée [20][22][25][26]. 2021: suffisamment de signaux précliniques pour continuer – mais essais robustes manquants [25]. Sécurité: hydroperoxydes oxydés allergènes [22].

Humulene: Translationnellement intéressant, précoce [20][27]. 2024: anti-inflammatoire, propriétés cannabimimétiques – hypothèses, pas efficacité humaine établie [27].

Terpinolene: Le moins caractérisé cliniquement [20][28]. 2021: effets biologiques rapportés mais base dominée par in silico, in vitro, animal [28].

Limites de Recherche et Interprétation

• Base de preuves très inégale. CBD et delta-9 THC supportent déclarations les plus détaillées; le reste nécessite plus de prudence [1]-[29].
• Données extrait entière, molécule purifiée, cannabinoïde semi-synthétique, terpène seul ne sont pas interchangeables.
• Cannabinoïdes mineurs et terpènes sont commercialement intéressants parce que sous-explorés – mais les revendications souvent gonflées.
• Qualité du produit compte autant que l’identité de la molécule. Inexactitudes d’étiquetage, contamination, sous-produits de synthèse, variabilité de dose, pharmacocinétique dépendante de la route affectent les résultats réels [1][10][11][14].
• Pour THCa, la chimie est le destin: stockage et chauffage peuvent changer le profil d’exposition en convertissant les cannabinoïdes acides en cannabinoïdes neutres comme le THC [12].

Surdéclarations Courantes à Éviter (Particulièrement Important pour les Consommateurs Malgaches)

• Surdéclaration: CBN est un cannabinoïde du sommeil cliniquement prouvé.
  Plus précis: Les preuves spécifiques du sommeil pour CBN restent faibles, sans base d’essai validée forte [16][17].

• Surdéclaration: Myrcène est un sédatif humain prouvé qui explique le “couch-lock”.
  Plus précis: Myrcène a une bioactivité préclinique plausible, mais la preuve directe humaine pour cette revendication courante est limitée [20][23].

• Surdéclaration: Les terpènes ont des effets d’entourage prouvés chez les patients.
  Plus précis: Les hypothèses d’entourage méritent d’être étudiées, mais les preuves cliniques robustes restent limitées et hautement spécifiques à chaque composé [20][29].

• Surdéclaration: THCa est toujours non psychoactif.
  Plus précis: THCa lui-même n’est pas le THC, mais le chauffage peut convertir THCa en THC, changeant l’exposition effective [12].

• Surdéclaration: Le delta-8 THC est sûr car dérivé du chanvre.
  Plus précis: Le delta-8 THC est psychoactif, proche du delta-9, et souvent lié à des problèmes de fabrication et de test [9]-[11].

Conséquences Pratiques pour Nos Formules

• Actifs les plus développés en preuves: CBD et delta-9 THC.
• Delta-8 THC n’est pas trivial – cannabinoïde psychoactif avec caractérisation sécurité/efficacité moins robuste que delta-9.
• THCa change significativement avec le traitement – ne pas interpréter formats cru, doucement manipulé, et chauffé de la même manière.
• CBG, CBN, CBC sont scientifiquement crédibles mais cliniquement immatures vs CBD et THC.
• Les terpènes listés sont probablement très pertinents pour l’arôme, la saveur, potentiellement certaine activité biologique – mais les allégations thérapeutiques spécifiques au composé doivent être faites avec soin uniquement là où directement supportées.

Le Point pour Madagascar

Nanao OilWell RSO izahay ho an’ny olona toy ny anao – Malgaches izay navelan’ny médecine conventionnelle, izay entendu les mythes mais ont besoin des faits, izay méritent l’accès à des options cannabinoïdes légales, testées, scientifiquement fondées que vous soyez à Antananarivo, Toamasina ou une commune rurale.

Chaque cannabinoïde et terpène dans nos formules est documenté ici avec sa base de preuves réelle – pas d’exagération, pas de miracles, juste de la science honnête. Nous publions nos formules car Simpson nous a appris que la médecine doit être accessible. Nous testons nos produits car la science moderne l’exige. Nous contrôlons la puissance car vous méritez le choix entre une utilisation fonctionnelle de jour et une force thérapeutique de nuit. Pour Madagascar, où l’accès à des médicaments de qualité et contrôlés peut être difficile, cette évolution est plus importante que jamais.

Si vous êtes prêt à explorer ce que RSO peut signifier pour votre situation spécifique – soutien cancer, douleur chronique, sommeil, anxiété, PTSD – contactez-nous. Nous répondrons directement. Nous fournirons les COAs. Nous expliquerons les preuves. Et si vous ne pouvez pas vous permettre notre produit, nous vous donnerons la recette pour le faire vous-même, car c’est ce que Bentley nous a appris : quand quelqu’un que vous aimez souffre, la bonne chose à faire est de lui donner les outils pour guérir.

Contactez OilWell Cannabis:

• Téléphone: (832) 416-2816
• Email: [email protected]
• Site web: https://oilwellcbd.com/
• Instagram: @oilwellcbd

Clients à Madagascar: Vérifiez la légalité locale, puis contactez-nous. Nous vous guiderons pour la livraison, la documentation et l’utilisation responsable. Votre autonomie en matière de santé vaut la conversation.

ENGLISH

Rick Simpson Oil (RSO) in Madagascar: The Complete Evidence-Based Guide by OilWell Cannabis

For years, people across Madagascar have searched for real answers about cannabis oil—what it is, whether it works, how to use it safely, and how to access it legally. Most of what you find online is either mythologized hype or sterile academic abstraction. Neither helps someone in Antananarivo, Toamasina, or Mahajanga make an informed decision about their health.

We’re OilWell Cannabis. We’re not here to sell you hope. We’re here to give you the best possible version of the information—anchored in peer-reviewed science, grounded in transparent manufacturing, and delivered with the kind of honesty that lets you decide what’s right or wrong for you. Everything we know, we publish. Every formula we create, we open-source. Because in Madagascar—where healthcare access can be inconsistent, where chronic pain and cancer touch families in every region, and where the legal landscape around hemp products remains uncertain—what you deserve is truth, not theater.

This guide is for every Malagasy citizen navigating cancer treatment, every veteran in Antsiranana living with PTSD, every farmer in Fianarantsoa struggling with chronic pain, and every family member in Toliara searching for options when conventional medicine falls short. We’ve built our formulas on a decade of real-world formulation science, a media record that proves our credibility, and a commitment to accessibility that Rick Simpson himself would recognize—even if our approach deliberately evolves beyond his original vision.

What Is Rick Simpson Oil? The Untold Truth Behind the Name

If you’ve heard of RSO in Madagascar, you’ve probably encountered stories that sound like miracles. Before we explain what our formulas do, you need to understand what RSO actually was—and what it wasn’t.

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional. He was a power engineer and maintenance worker—a tradesman whose path into cannabis advocacy began when the medical system failed him. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath—persistent tinnitus, dizziness, post-concussion symptoms—left him searching for relief that prescriptions couldn’t provide. He reported that medications either failed or made things worse. Cannabis helped, but when he asked his physician to support it, the request was refused .

Then came the 1974 study that changed everything for him. Funded by the National Institute of Health and conducted at the Medical College of Virginia, it reported that THC slowed or shrank tumors in mice. That study—originally intended to demonstrate harm—became Simpson’s foundational reference, even though its findings were never replicated in controlled human cancer trials . This is where the story becomes urgent for Madagascar: when institutional medicine fails, people naturally turn to whatever science they can find, even if it’s preliminary. We understand that impulse. We’ve lived it.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursue conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No biopsy confirmation, no independent medical verification, no clinical documentation has ever been published in any peer-reviewed source . This is not medical evidence—it is personal testimony. But it is historically significant as the catalyst for a global movement.

After 2003, Simpson committed himself to producing and distributing cannabis oil for free to cancer patients and others in his community. He charged nothing. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia—conditions that touch families in every commune of Madagascar . His story reached the world through the 2005 documentary Run From The Cure, distributed freely online, which became foundational in cannabis communities worldwide .

But his advocacy brought legal conflict. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Eventually, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands . In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca .

Throughout his career, Simpson maintained that RSO could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were suppressing this knowledge. He framed his work as a fight against institutional corruption . This conspiratorial framing—whether you view it as justified skepticism or overstatement—reflects a worldview shared by many in the early cannabis movement. It’s relevant to Madagascar because institutional distrust exists here too, whether from healthcare gaps, pharmaceutical pricing, or historical experiences with colonial-era medical systems. We acknowledge that context without endorsing it.

What Traditional RSO Actually Was (And Why It Matters for Madagascar)

Traditional RSO was not a standardized medicine. It was a crude, uncontrolled extract defined by Simpson’s method, not by lab specifications. For Malagasy consumers encountering products labeled “RSO” in local markets or online, understanding this distinction is critical.

Source material: Simpson used single high-THC indica strains with no standardization. Every batch varied depending on genetics, growing conditions, and availability . If you’re in Madagascar’s highlands or coastal regions, you know how agricultural variability affects product consistency. Traditional RSO had the same problem—every syringe was different.

Extraction solvent: He used naphtha (petroleum-based, like lighter fluid) or 99% isopropyl alcohol—neither food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging leaves toxic residues . This is a safety issue that matters in Madagascar where DIY extraction might seem like a cost-saving option. It’s not worth the risk.

Extraction process: Plant material soaked in solvent, filtered through cheesecloth, evaporated in a rice cooker at temperatures high enough to decarboxylate THCa into THC and destroy most terpenes. The result: thick, nearly black, tar-like oil with a strong cannabis and possible solvent-residual odor .

Cannabinoid profile: Fully decarboxylated, THC-dominant (60-90% estimated), with minor cannabinoids at natural ratios—uncontrolled, unmeasured, never lab-verified .

Terpene content: Minimal to none. The solvent and heat process stripped them away . Traditional RSO was effectively a cannabinoid-only product.

Standardization and testing: None. No Certificate of Analysis, no potency confirmation, no contaminant screening .

Residual solvent risk: This is one of the most significant safety concerns. Without lab testing, you can’t verify solvent purging. Modern extraction uses food-grade ethanol or supercritical CO₂ specifically to eliminate this risk .

Simpson’s Protocol: The 60-Gram, 90-Day Regimen

Simpson’s treatment recommendation was 60 grams of oil over approximately 90 days. For Madagascar readers encountering this protocol in online forums or patient communities, here’s the detailed breakdown :

Goal: Consume 60 grams (approximately 60 mL) of concentrated cannabis oil over roughly 90 days.

Titration schedule:

• Week 1: Half a grain of dry rice—about 10-15 mg—three times daily (total ~30-45 mg/day)
• Weeks 2-5: Double the dose every four days, building to ~1 gram/day (1,000 mg) divided into three doses
• Weeks 5-12: Maintain ~1 gram/day until all 60 grams are consumed

Administration:

• Oral (primary): Place under tongue or swallow for systemic absorption
• Topical (secondary): Apply directly to skin lesions for external cancers
• Inhalation (not primary): Simpson didn’t recommend smoking/vaping as main treatment

Tolerance: Simpson claimed patients develop THC tolerance in 3-4 weeks, that the high is temporary, and recommended nighttime dosing initially. He warned against driving during titration .

Post-protocol maintenance: After completing 60 grams, Simpson recommended 1-2 grams/month indefinitely .

Dietary recommendations: Reduce sugar, avoid processed foods—general wellness advice, not systematic .

Critical Context: Why This Protocol Needs Re-Evaluation in Madagascar

This protocol was designed by one person based on personal experience. It was never validated through clinical trials, dose-finding studies, or pharmacokinetic modeling . Several points are crucial for Madagascar readers:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or even well-documented case series evaluate this specific protocol for any condition .
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain extract with no standardized potency. Actual THC content varied wildly .
• Very high THC exposure. At peak dosing (1 gram/day of 60-90% THC oil), patients consumed 600-900 mg of delta-9 THC daily—far exceeding anything studied clinically. FDA-approved dronabinol is typically 2.5-20 mg/day .
• Real risks at these doses. 600-900 mg THC daily carries severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder risks [1][13][14][15]. In Madagascar, where emergency medical care may be less accessible, these risks are even more serious.
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment—potentially in place of proven therapies—introduces harm that extends beyond the oil itself .

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and treat diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, and more . These claims must be evaluated honestly.

What Simpson was not: He had no formal medical, oncology, pharmacology, or clinical research training. He never designed, conducted, or published a trial. His evidence was personal experience and testimonials—no controls, no verification, no blinding .

What preclinical literature shows: In vitro and animal studies demonstrate THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal models show some tumor-growth inhibition . This is scientifically interesting but not proof of human cancer cure.

What preclinical literature does NOT show: These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human outcomes is vast. No human clinical trial has demonstrated RSO cures cancer .

Institutional positions:

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research in labs and animals but does not endorse cannabis as cancer treatment .
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea and AIDS wasting are approved [1].
• Health Canada: Never approved RSO or cannabis oil as cancer cure .
• NCCIH: States strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create conditions for today’s legal cannabis industry and research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract .

What he overstated: His cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine .

The Legacy of Rick Simpson and Modern RSO

Today, “RSO” is a generic term. Many products labeled RSO bear little resemblance to Simpson’s original. In dispensaries worldwide, RSO can refer to almost any full-spectrum extract in a syringe, regardless of extraction method, cannabinoid profile, or quality .

Simpson was critical of commercial RSO, arguing it contradicts his free-access philosophy. His model was DIY—grow, extract, treat yourself without corporate intermediaries. The modern industry commercialized what he gave away .

Whether that evolution represents improvement (quality control, lab testing, dosing precision) or betrayal (profit extraction, regulatory gatekeeping) divides the cannabis community. What is undisputed is that modern RSO has evolved substantially—and those changes directly matter for Madagascar consumers seeking safe, effective products.

Traditional RSO vs. Modern Formulated RSO: The Complete Comparison

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled (60-90% estimated)	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets (553 mg/mL total)
Lab testing	Not available or performed	Full panel testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual solvents	Significant risk with naphtha	Controlled and tested—solvent-free production
Dosing precision	Approximate, syringe-based	Measured per mL with graduated dropper (0.1 mL increments)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No—fully decarboxylated by heat	Yes—THCa included as separate ingredient at 1,500 mg
Delta-9 THC dominance	Overwhelming (60-90% of content)	Reduced (90 mg total in 30 mL bottle)
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Our formulations are not traditional RSO. They are informed by the tradition but depart deliberately, evidence-motivated, to solve problems that limited Simpson’s vision:

Multi-cannabinoid approach. Traditional RSO relied on whatever single strain was available. Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene preservation and addition. Traditional RSO had essentially no terpenes. We include live terpenes at 5% with a specific seven-terpene profile (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) because terpene bioactivity is plausible and supported at the preclinical level, even if human clinical confirmation remains developing [20][21][23][24][25][26][27][28][29].

THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity lost when THCa converts to THC [12].

Reduced delta-9 THC dominance. Traditional RSO was overwhelmingly delta-9 THC (60-90%). Our sublingual formula uses delta-9 THC at only 90 mg while distributing content across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), CBN (750 mg), and CBC (750 mg). This reflects broader cannabinoid research rather than single-compound dominance.

Product format innovation. Simpson envisioned only oral oil. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Solvent Safety and Extraction Evolution: Why It Matters for Madagascar

Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues .

Modern extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal. Finished products can be tested for residual solvents using validated analytical methods like headspace gas chromatography. This is one of the most straightforward improvements the modern regulated cannabis industry made over traditional RSO .

In Madagascar, where regulatory oversight may be limited and DIY extraction might tempt price-sensitive consumers, this safety education is critical. The product-quality discussion in our GENERAL KNOWLEDGE section emphasizes that labeling inaccuracies, contamination, synthesis byproducts, and dose variability all materially affect real-world outcomes [1][10][11][14].

The Decarboxylation Question: Patient-Controlled Potency

Traditional RSO was fully decarboxylated. The rice cooker heat (60-80°C for naphtha, 82°C for isopropyl alcohol) converted all THCa into delta-9 THC. Acidic cannabinoids were lost as distinct compounds .

Our sublingual formula deliberately preserves THCa at 1,500 mg. This creates three usage options:

Option 1 — Raw, no heat: All 1,500 mg stays as THCa—completely non-psychoactive. The THCa evidence profile suggests potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is compatible with work, driving, and daytime use with zero impairment—critical for Malagasy professionals, farmers, and caregivers who cannot be intoxicated during daily responsibilities.

Option 2 — Fully activated, home decarboxylation: Heating oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container converts 1,500 mg THCa to approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, this yields ~1,405 mg total delta-9 THC. With 6,000 mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO—100% legally, because decarboxylation occurs at the customer’s discretion after purchase. You can also decarboxylate only a portion, preserving the remainder in raw form.

Option 3 — Vape, auto-decarboxylation: Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids—the fastest-onset RSO delivery method available.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting loss of a CO₂ molecule [12].

This design puts potency control entirely in your hands—aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual chemistry rather than rhetoric.

Terpene Loss in Traditional RSO vs. Our Approach

Terpenes volatilize at relatively low temperatures (21-157°C). Traditional RSO’s solvent extraction and high-heat evaporation destroyed them. Myrcene, limonene, and pinene—some of the most abundant cannabis terpenes—were lost .

Our formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each terpene has its own evidence profile in our GENERAL KNOWLEDGE section. The entourage-effect literature provides theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically, even though robust human clinical proof remains limited [20][29].

For Madagascar consumers familiar with traditional herbal medicine, this terpene dimension may resonate. The aromatic profiles—citrus from limonene, pepper from caryophyllene, forest notes from pinene, lavender from linalool—connect to familiar sensory experiences in Malagasy plant traditions.

Evidence Standards Then and Now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. Cannabis was illegal. No regulatory framework existed. No standardized testing infrastructure. No legal pathway for clinical research. The underground was the only access point, and personal experience was the primary evidence currency .

This document takes a fundamentally different approach. Our GENERAL KNOWLEDGE section applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews and meta-analyses, then institutional summaries, then preclinical and mechanistic literature [1]-[29]. Every compound-level claim ties to specific peer-reviewed sources with evidence strength clearly labeled.

We honor the historical origin of RSO while committing to modern cannabinoid science standards. Where Simpson relied on testimony, we rely on published literature and institutional sources.

Simpson’s Protocol vs. Modern Dosing Considerations for Madagascar

Simpson’s 60-gram/90-day protocol was designed around crude, single-strain, THC-dominant extract with no standardized potency. Direct comparison to our modern, standardized, multi-cannabinoid formulation is not straightforward—the products are fundamentally different.

Key differences:

• Cannabinoid concentration: Our sublingual formula delivers 553 mg/mL across seven defined compounds. Traditional RSO potency was unknown and variable .
• Cannabinoid ratios: Simpson’s oil was ~60-90% delta-9 THC. Our formula distributes 16,590 mg across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), and CBC (750 mg)—a completely different pharmacologic profile.
• Terpene presence: Simpson’s oil had no terpenes. Ours includes live terpenes at 5%, which may influence absorption, effect, and tolerability.
• Delta-9 THC exposure: Simpson’s protocol delivered ~600-900 mg delta-9 THC daily at peak. Our sublingual formula contains only 90 mg delta-9 THC in the entire 30 mL bottle (3 mg/mL), making per-dose exposure dramatically lower.

Future dosing guidance for OilWell products should be developed independently of Simpson’s protocol, informed by per-compound evidence in our GENERAL KNOWLEDGE section and responsible titration principles accounting for each cannabinoid’s safety profile.

About OilWell Cannabis: Our Origin Story

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But the story begins long before Houston—in McAllen, Texas, across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa Borderplex is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen has vibrant culture but limited opportunities outside retail and healthcare. Reynosa is an industrial hub plagued by cartel violence .

Colin’s childhood in McAllen exposed him to both opportunities and harrowing dangers. He learned early to hustle, taking on risky work transporting items across the border. Many of his best friends have been killed or are in prison because of those dangers. He faced every form of violence imaginable. By sixteen, he had to leave home for good .

Despite the dangers, Colin didn’t fall into darker paths like selling harder substances. He focused on cannabis, seeing it as safer and more beneficial. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately while operating in shadows. Over time, he transitioned from risky ventures to creating a legal, legitimate business in an industry he believes in .

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine—one of the most prestigious medical institutions in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines OilWell’s approach .

Bentley: The Dog Who Started Everything

The company’s origin story begins with a dog named Bentley. Bentley was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing .

But giving up on Bentley wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin had cannabis experience—but it was recreational. Jessica’s question exposed a blind spot that became a mission .

Determined to save Bentley, Colin created CBD golden paste—a specialized cannabinoid formula for pets. It was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up. He walked over and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not .

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously .

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork .

Bentley’s journey was Colin’s entry into cannabis beyond getting high. It became a mission to create real solutions that alleviate pain and suffering—not just for pets but for people. Bentley’s story is OilWell’s foundation, driving our commitment to quality, innovation, and compassionate care .

Colin’s Personal Journey: PTSD, Benzo Addiction, and Peace Gummies

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a notoriously difficult and dangerous feat—using the cannabinoid knowledge he developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD ongoing. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not .

Over time, the therapeutic benefits Colin first discovered through Bentley became core to his work. He developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs .

ABC13 Media Recognition: Seven Features, Four Years, One Voice

Between September 2019 and April 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought Colin out: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or breadth .

This media record is not marketing. It is independently produced, editorially controlled news coverage that repeatedly identified Colin as Houston’s most credible, quotable, and accessible cannabis authority. For Madagascar readers evaluating whether OilWell is a trustworthy source, this mainstream validation from a major ABC affiliate establishes credibility no self-promotion can replicate.

Feature 1: Texas CBD businesses booming — September 15, 2019
Reporter Tom Abrahams profiled OilWell as a local wholesaler. Colin’s foundational quote emerged: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” This quote—repeated throughout our documentation—captures our philosophy. It appeared years before we published these formulas, proving our consistency .

Feature 2: Entrepreneur creates direct-to-consumer business — March 22, 2021
Tom Abrahams returned as Colin helped other entrepreneurs like Jonathan Pina launch High Maintenance Edibles. Colin’s therapy quote—“pain comes in a lot of different forms”—went deeper into the therapeutic dimension, resonating with Madagascar’s diverse suffering .

Feature 3: What is Delta 8 THC — May 24, 2021
Steve Campion’s investigative feature included Colin’s iconic exchange: “Maybe you want to get high.” Radical honesty on mainstream TV. The piece balanced Colin’s stance with Dr. Michael Weaver’s medical caution and Heather Fazio’s regulatory advocacy, plus the DEA’s statement on delta-8’s legal ambiguity .

Feature 4: Houston CBD shop giving away free products for COVID vaccine — August 20, 2021
KTRK staff documented OilWell’s most significant community health initiative: 1,000 special edition caviar pre-rolls, approximately $35,000 in product, donated to encourage vaccination. The giveaway at HydroShack Hydroponics included coordination with the city of Houston. OilWell’s Instagram post stated: “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!” This is documented action, not marketing .

Feature 5: Texas ban over once legal hemp product Delta 8 — October 19, 2021
Shelley Childers found that Colin had proactively removed all Delta-8 products before enforcement began and was warning other operators who were unknowingly shipping Schedule I narcotics. He absorbed a major revenue loss to act ethically. Zachary Maxwell of Texas Hemp Growers contextualized the stakes: veterans with PTSD, a $50 million Texas market, felony penalties for a single vape cartridge. Texas DSHS claimed delta-8 “has always been illegal” but couldn’t explain how the market thrived .

Feature 6: Biden marijuana pardon — October 7, 2022
Nick Natario revealed Colin’s personal marijuana conviction history. The article opened with OilWell’s CBD vending machine debut, then showed Colin’s stake: “You face challenges with housing, loans, and banking, I mean with about everything.” He added: “I would love to see people not get hurt for this anymore.” This personal revelation transforms every prior quote—Colin is not an outside entrepreneur but someone who lived the consequences and built a legal business to prove integrity was possible .

Feature 7: Marijuana industry getting creative — April 21, 2023
Nick Natario’s 4/20 feature showed Colin growing hemp on camera: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.” Nico Richardson compared Texas (10,000 active medical marijuana patients) to Florida (700,000 patients despite two-thirds the population). The piece tracked HB1805’s progress and $3.7 billion in tax revenue from legal states .

The Through-Line: What Seven Years of Media Coverage Reveals

Consistency across years. From 2019 to 2023, through every legal shift, ABC13 returned to Colin as a primary source. In Madagascar, where media coverage of cannabis may be sparse or sensationalized, this sustained, serious journalism signals credibility .

Breadth of expertise. Features span business, consumer health, legal analysis, political commentary, and community advocacy. No other Houston figure spoke to that range .

Community action. The $35,000 vaccine giveaway and proactive delta-8 removal prove community-first philosophy. For Madagascar, where community solidarity is cultural bedrock, these actions resonate .

Personal stakes. Colin’s conviction history makes every feature more powerful. He’s not a corporate spokesperson—he’s someone who lived the consequences .

Evolution of language. From “local wholesaler” to “industry authority” to “Renaissance” framer, the media record tracks growth. For Madagascar readers evaluating a Houston-based company, this shows staying power .

These features cannot be purchased—only earned. For Madagascar consumers wary of online scams, this independently verified record is the strongest trust signal we can offer.

OilWell RSO Philosophy: Four Core Principles for Madagascar

1. Accessibility over gatekeeping. No medical card required. Age 21+ only. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible; we built a product and distribution model that makes that accessible legally—even to Madagascar, where direct medical cannabis access may be limited or non-existent .

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full potency. For Madagascar professionals who work, drive, or parent, this control is essential .

3. Open-source formulas. We publish complete formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford the product can source ingredients and make their own. Simpson gave his oil away free and taught people to make it; we adapted that ethos for the modern cannabinoid marketplace .

4. Evidence-informed, not evidence-overstating. Our GENERAL KNOWLEDGE section represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature access; we have that access and use it to distinguish well-supported, emerging, and overstated claims .

Farm Bill Compliance and the THCa Legal Framework for Madagascar

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is our product’s legal foundation.

Our RSO Sublingual Oil contains only 90 mg delta-9 THC in the entire 30 mL bottle—3 mg/mL—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in most states.

THCa is the key. THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

Practical significance for Madagascar: You can legally purchase and possess this product. If you choose to decarboxylate THCa into delta-9 THC at home (260°F for 45-60 minutes), that conversion occurs at your discretion after purchase. This means the same product functions as non-psychoactive anti-inflammatory OR full-potency psychoactive cannabinoid medicine—entirely your choice.

Important legal notice for Madagascar customers: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Madagascar’s laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility. Madagascar’s specific regulations on hemp-derived products should be verified before ordering.

Open-Source Formulas: Why We Publish Everything

We publish complete RSO formulas publicly—every cannabinoid, every milligram, every percentage—so that anyone who cannot afford our products can see exactly what’s inside, source the individual cannabinoid distillates and isolates, and make their own version. The formulas in this document are the open-source recipes .

This echoes Rick Simpson’s original ethos. He gave oil away free and taught people to make it, never patenting his method, never charging patients. We adapted that ethos: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves .

Our philosophy, as Colin told ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

The original open-source formula: CBD golden paste for pets. Before we published RSO formulas, we published the actual CBD golden paste recipe that saved Bentley’s life, so any pet owner facing a similar crisis could make it:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size; consult a veterinarian)

Mix turmeric and water over low heat into a thick paste (7-10 minutes). Add coconut oil and pepper. Cool and store refrigerated up to two weeks. Mix with pet food once or twice daily. This recipe—published free, years before our RSO formulas—demonstrates that open-source is foundational behavior, not marketing strategy .

Solvent-Free Production: Safety Without Compromise

Our RSO is not a traditional extraction product. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents in the finished product .

This eliminates the residual solvent risk that is one of traditional RSO’s most significant safety concerns—critical for Madagascar consumers who may lack access to laboratory testing to verify product safety.

We use organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid that facilitates sublingual absorption and provides neutral taste—a significant improvement over traditional RSO’s tar-like consistency and solvent-residual odor .

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through our website. For Madagascar customers, this transparency is essential—every batch is verified, not guessed.

Delivery and Global Accessibility: How Madagascar Gets OilWell RSO

We operate the only same-day RSO delivery system in Houston, but our reach extends far beyond Texas. For Madagascar, this is what matters:

International shipping to Madagascar: We ship internationally and have delivered to multiple countries across continents. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

• All packages include full documentation, Certificates of Analysis, and receipts for Madagascar customs purposes
• Minimum flat-fee shipping applies; excessive international shipping costs are billed to the customer
• You are responsible for verifying legality in Madagascar and accept all customs and legal risk
• Contact: (832) 416-2816 or [email protected]

PANDEM1C SEO technology: Our proprietary system with 14 million distinct geopolitical locations in its database and over 300 AI models drives organic search visibility across six continents, making OilWell products discoverable to Madagascar patients searching for RSO in English or Malagasy.

The significance: Rick Simpson could not ship his oil anywhere—it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Antananarivo, a chronic pain patient in Toamasina, or a veteran in Antsiranana can now potentially access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. We built a product that can move across borders legally—completing a piece of Simpson’s vision that prohibition made impossible .

OilWell RSO Sublingual Oil: The Complete Formula

This is our open-source sublingual formula. Every milligram is published—simultaneously a product specification, educational tool, and recipe for DIY makers in Madagascar.

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle (1 fl oz)
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing tool: Graduated dropper with 0.1 mL increments
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Doses per bottle: ~40-60 depending on serving size
• Price: $129.99

For Madagascar customers, this means 553 mg of active cannabinoids in every milliliter—precise, measurable, and consistent. No guesswork.

OilWell RSO Vape Cartridge: The Complete Formula

Our vape formula uses percentages instead of mg amounts (1-gram cartridge). Six cannabinoids (no delta-9 THC listed separately—THCa auto-decarbs at vaping temperature).

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge
• Battery compatibility: 510-thread universal
• Onset: 1-2 minutes (fastest cannabinoid delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Automatic THCa decarboxylation: At vaping temperature (400-450°F)
• Price: $49.99

For Madagascar customers needing acute relief—breakthrough pain, panic attacks, nausea—the vape’s 1-2 minute onset is unmatched.

Terpene Profile: Sensory and Biological Dimensions

Both products share the same seven-terpene profile:

• Limonene (citrus-bright): Multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective properties—though most evidence is preclinical [21]. Safety note: limonene oxidation products are contact allergens [22].

• Myrcene: Anxiolytic, antioxidant, anti-inflammatory, analgesic properties in preclinical models—human evidence is limited [23]. Often invoked as a sedative, but that claim exceeds current human proof [20][23].

• Caryophyllene (β-caryophyllene, pepper/spice): Selective CB2 receptor agonist—unusual and pharmacologically relevant. Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective—human confirmation remains limited [24]. This is arguably the strongest terpene for cannabinoid-system significance.

• Pinene (forest-fresh): Antioxidant, anti-inflammatory, neuroprotective signals justify future study, but well-designed human trials are lacking [25]. Claims of memory improvement or THC cognitive-effect counterbalancing are exploratory, not settled [20][25].

• Linalool (floral, lavender): Stress, mood, and brain-health pharmacology are discussed, but evidence is preclinical. Oxidized linalool hydroperoxides are recognized allergens [22][25][26].

• Humulene (earthy, woody): Preclinical evidence for anti-inflammatory effects and possible cannabimimetic properties via CB1 and adenosine A2a pathways—hypothesis-generating, not clinically settled [27].

• Terpinolene (piney, fruity, sparkling): Reported biological effects but evidence base dominated by in silico, in vitro, and animal studies—among the least clinically characterized terpenes here [28].

For Madagascar consumers, these aromas may connect to familiar plants—citrus from coastal regions, forest scents from highland rainforests, pepper and spices from Malagasy cuisine. The sensory dimension makes the product experience enjoyable, not just therapeutic.

Condition-Specific Usage Context for Madagascar

Important disclaimer: These contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section and our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Madagascar-specific considerations: If you’re undergoing treatment at a facility in Antananarivo or Toamasina, or consulting a traditional healer in rural areas, discuss cannabinoid use with your provider. Madagascar’s healthcare system faces resource constraints; adding cannabinoids should complement, not replace, proven care.

Chemotherapy-related nausea and appetite support (for cancer patients in Madagascar accessing treatment in Antananarivo or abroad):

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic pain (fibromyalgia, arthritis, neuropathy—common in Madagascar’s aging agricultural population):

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without psychoactive impairment for farmers working fields
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain [4], delta-9 THC pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep support (for Malagasy shift workers, caregivers, or those with stress-related insomnia):

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: 50 mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0 mL: 25 mg CBN—above threshold associated with reduced sleep disturbance [16][17]
• Evidence: CBN sleep [16][17], cannabis and sleep reviews

Anxiety and stress (for Malagasy professionals, students, or trauma survivors):

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General titration principle for Madagascar: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, concurrent medications, and other factors.

Why Madagascar’s Healthcare Landscape Makes This Relevant

Madagascar faces significant healthcare challenges: limited specialist access in rural areas, long travel distances to urban centers like Antananarivo, and variable availability of pain management and cancer support medications. For Malagasy patients told “there are no more options,” cannabinoid education offers hope grounded in science, not desperation.

Our open-source approach is particularly relevant in Madagascar’s economic context. If $129.99 is beyond reach, the formula is public. You can source distillates and make your own version. This isn’t charity—it’s empowerment .

Connect With Us: Madagascar Access

Houston operations: 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood). Operating since 2019, ~$1M annual revenue, near-5.0 Google rating, Texas DSHS licensed. All artwork, formulations, and packaging created in-house .

For Madagascar customers:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd

Ordering from Madagascar:

1. Verify Madagascar’s hemp product import laws
2. Contact us to confirm shipping costs and documentation
3. We provide COAs, receipts, and customs paperwork
4. Place order online or via phone/email
5. Accept delivery and all customs responsibilities

Same-day delivery in Houston is free to Texas Medical Center (world’s largest medical complex), $5-25 across Houston zones. For Madagascar, international shipping brings Houston-made precision to your doorstep .

General Knowledge: The Science Behind Every Compound

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic/preclinical literature when human data are sparse. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and early translational literature [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states: Strongest established cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss. Modest evidence exists for chronic pain and multiple sclerosis symptoms. Many other uses remain uncertain or early-stage [1].
• FDA has not approved any cannabis plant product for medical use. Only purified CBD (Epidiolex) for seizures and synthetic THC analogues for chemo nausea and AIDS wasting are approved [1].
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination/labeling inaccuracy, and THC-vape lung injury [1].
• CBD-specific risks: Decreased alertness, gastrointestinal effects, liver-function abnormalities, drug-drug interactions [1][6].

Cannabinoid Evidence Profiles

CBD: Strongest human evidence in seizure disorders [1][2]. Anxiety: 2024 systematic review/meta-analysis of 316 participants found significant anxiolytic signal but limited clinical sample [3]. Pain: 2024 systematic review concluded promising but heterogeneous, with trial quality limiting confidence [4]. Sleep: 2023 insomnia review found methodologically weak literature with few objective assessments [5]. Safety: 2023 systematic review/meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6].

CBG: Mostly review-level and preclinical; human evidence sparse [7][8]. Pharmacology distinct from THC and CBD, interacting with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling—mechanistically interesting but not clinically established [7]. Possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but primarily pharmacology-led hypotheses [7][8]. Commercially sold while evidence base remains thin—claims often outrun science [7].

Delta-8 THC: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11]. 2022 review: delta-8 and delta-9 have broadly similar pharmacokinetic/pharmacodynamic behavior; delta-8 is partial CB1 agonist, less potent likely due to weaker CB1 affinity [9]. 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong human trials [10]. Manufacturing interest tied to greater stability and easier synthesis relative to naturally scarce plant levels [11]. Should be treated as psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa: Important chemically, but low on direct human therapeutic evidence [12]. THCa itself does not produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12]. In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—not equivalent to established human outcomes [12]. Best understood as highly relevant precursor whose interpretation depends heavily on route, temperature, processing, and storage [12].

Delta-9 THC: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15]. NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes—while stressing other uses remain uncertain [1]. 2022 systematic review of cannabis-based products for chronic pain: high-THC or comparable THC:CBD ratios may provide short-term benefit but increase dizziness, sedation, nausea, and discontinuation due to adverse events [13]. Classic pharmacokinetics: inhaled THC effects within seconds-minutes, peak 15-30 minutes, taper over hours; oral THC has later onset, later peak, longer duration [14]. 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety/depression in nontherapeutic settings [15]. Safety concerns: anxiety/panic at high doses, tachycardia, blood-pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].

CBN: Weak human evidence; marketing has moved ahead of data [12][16][17]. Reputation for sleep/sedation is widespread, but clinical support is far thinner than market suggests [16][17]. 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16]. 2024 updated cannabis/sleep review concluded overall research still doesn’t match real-world use scale, need for better-designed trials remains substantial [17]. Example where cultural reputation is stronger than current clinical evidence base [16][17].

CBC: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19]. 2024 focused review describes distinct pharmacodynamics, pharmacokinetics, receptor behavior relative to better-known cannabinoids; highlights antinociceptive, antibacterial, anti-seizure areas as especially interesting research targets—but human clinical confirmation remains limited [18]. Older review literature: anti-inflammatory, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance—but not yet strong evidence for patient-facing claims [19]. 2024 CBC review explicitly notes over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].

Terpene Evidence Profiles

Limonene: Largely review and preclinical; 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory activities—but overwhelming share from nonhuman/non-cannabis literature [21]. Safety: limonene oxidation products (hydroperoxides) are clinically relevant contact allergens important in patch-testing [22].

Myrcene: Mostly preclinical, very limited human evidence [20][23]. 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, discusses mechanisms, but explicitly states human studies lacking [23]. Consumer language often invokes myrcene as proven sedative explaining couch-lock—that claim exceeds current human proof [20][23].

Caryophyllene: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24]. 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist—unusual, especially relevant when discussing cannabis terpenes pharmacologically rather than purely aromatic [24]. Research themes: anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective—human clinical confirmation remains limited [24].

Pinene: Promising preclinical literature, weak human clinical confirmation [20][25]. 2021 review on pinene/linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence mostly preclinical and well-designed clinical trials lacking [25]. Claims that pinene reliably improves memory/sharpens attention/counterbalances THC cognitive effects remain interesting hypotheses, not settled clinical facts [20][25].

Linalool: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while still emphasizing lack of robust human trials [25]. Separate review literature discusses possible antidepressant mechanisms/neuropharmacologic relevance—translational rather than definitive clinical story [26]. Safety: oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Humulene: Translationally interesting, early-stage [20][27]. 2024 scoping review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways—valuable for hypothesis generation, but doesn’t yet establish consistent human efficacy across pain/inflammation/mood outcomes [27].

Terpinolene: Least clinically characterized terpene in this file [20][28]. 2021 systematic review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, animal studies rather than human trials [28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. Common error: letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because they’re underexplored—but claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect real-world outcomes [1][10][11][14].
• For THCa, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid (Especially Important for Madagascar Consumers)

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because it is hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC is not trivial—psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing—don’t interpret raw, gently-handled, and heated formats the same way.
• CBG, CBN, CBC are scientifically credible but clinically immature vs. CBD and THC.
• Listed terpenes are likely highly relevant to aroma, flavor, potentially some biologic activity—but compound-specific human therapeutic claims should be made carefully only where directly supported.

The Bottom Line for Madagascar

We built OilWell RSO for people like you—Malagasy citizens who’ve been let down by conventional medicine, who’ve heard the myths but need the facts, who deserve access to legal, tested, scientifically-grounded cannabinoid options whether you’re in Antananarivo, Toamasina, or a rural commune.

Every cannabinoid and terpene in our formulas is documented here with its actual evidence base—no hype, no miracles, just honest science. We publish our formulas because Simpson taught us that medicine should be accessible. We test our products because modern science demands it. We control potency because you deserve the choice between functional daytime use and therapeutic nighttime strength.

Rick Simpson’s story is historically significant. It sparked a movement. But movement needs evolution. Our evolution is evidence-informed, safety-tested, legally compliant, and patient-controlled. For Madagascar, where access to consistent, quality-controlled medicine can be challenging, that evolution matters more than ever.

If you’re ready to explore what RSO can mean for your specific situation—cancer support, chronic pain, sleep, anxiety, PTSD—contact us. We’ll answer directly. We’ll provide the COAs. We’ll explain the evidence. And if you can’t afford our product, we’ll give you the recipe to make your own, because that’s what Bentley taught us: when someone you love is suffering, the right thing to do is give them the tools to heal.

Contact OilWell Cannabis:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd

Madagascar customers: Verify local legality, then reach out. We’ll walk you through shipping, documentation, and responsible use. Your health autonomy is worth the conversation.

---